Full wwPDB EM Validation Report i○
Dec 13, 2020 – 05:16 PM EST
PDB ID : 6D6VEMDB ID : EMD-7821
Title : CryoEM structure of Tetrahymena telomerase with telomeric DNA at 4.8Angstrom resolution
Authors : Jiang, J.; Wang, Y.; Susac, L.; Chan, H.; Basu, R.; Zhou, Z.H.; Feigon, J.Deposited on : 2018-04-22
Resolution : 4.80 Å(reported)
This is a Full wwPDB EM Validation Report for a publicly released PDB entry.
We welcome your comments at [email protected] user guide is available at
https://www.wwpdb.org/validation/2017/EMValidationReportHelpwith specific help available everywhere you see the i○ symbol.
The following versions of software and data (see references i○) were used in the production of this report:
EMDB validation analysis : 0.0.0.dev61MolProbity : 4.02b-467
Percentile statistics : 20191225.v01 (using entries in the PDB archive December 25th 2019)Ideal geometry (proteins) : Engh & Huber (2001)
Ideal geometry (DNA, RNA) : Parkinson et al. (1996)Validation Pipeline (wwPDB-VP) : 2.15.1
Page 2 Full wwPDB EM Validation Report EMD-7821, 6D6V
1 Overall quality at a glance i○
The following experimental techniques were used to determine the structure:ELECTRON MICROSCOPY
The reported resolution of this entry is 4.80 Å.
Percentile scores (ranging between 0-100) for global validation metrics of the entry are shown inthe following graphic. The table shows the number of entries on which the scores are based.
Metric Whole archive(#Entries)
EM structures(#Entries)
Clashscore 158937 4297Ramachandran outliers 154571 4023
Sidechain outliers 154315 3826RNA backbone 4643 859
The table below summarises the geometric issues observed across the polymeric chains and their fitto the map. The red, orange, yellow and green segments of the bar indicate the fraction of residuesthat contain outliers for >=3, 2, 1 and 0 types of geometric quality criteria respectively. A greysegment represents the fraction of residues that are not modelled. The numeric value for eachfraction is indicated below the corresponding segment, with a dot representing fractions <=5%The upper red bar (where present) indicates the fraction of residues that have poor fit to the EMmap (all-atom inclusion < 40%). The numeric value is given above the bar.
Mol Chain Length Quality of chain
1 A 1117
2 D 701
3 F 121
4 E 269
5 B 159
6 C 19
7 G 157Continued on next page...
Page 3 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Length Quality of chain
8 H 542
Page 4 Full wwPDB EM Validation Report EMD-7821, 6D6V
2 Entry composition i○
There are 9 unique types of molecules in this entry. The entry contains 17317 atoms, of which 0are hydrogens and 0 are deuteriums.
In the tables below, the AltConf column contains the number of residues with at least one atomin alternate conformation and the Trace column contains the number of residues modelled with atmost 2 atoms.
• Molecule 1 is a protein called Telomerase reverse transcriptase.
Mol Chain Residues Atoms AltConf Trace
1 A 980 Total C N O S8253 5357 1369 1498 29 0 0
• Molecule 2 is a protein called Telomerase-associated protein 82.
Mol Chain Residues Atoms AltConf Trace
2 D 185 Total C N O S1538 985 255 290 8 0 0
• Molecule 3 is a protein called Telomerase holoenzyme TEB heterotrimer Teb3 subunit.
Mol Chain Residues Atoms AltConf Trace
3 F 113 Total C N O S919 580 155 180 4 0 0
• Molecule 4 is a protein called Telomerase holoenzyme Teb2 subunit.
Mol Chain Residues Atoms AltConf Trace
4 E 149 Total C N O S1207 765 211 223 8 0 0
• Molecule 5 is a RNA chain called RNA (159-MER).
Mol Chain Residues Atoms AltConf Trace
5 B 159 Total C N O P3322 1494 568 1102 158 0 0
• Molecule 6 is a DNA chain called DNA (5’-D(P*GP*TP*TP*GP*GP*GP*GP*TP*TP*GP*GP*GP*GP*TP*TP*GP*GP*GP*G)-3’).
Mol Chain Residues Atoms AltConf Trace
6 C 19 Total C N O P406 190 77 120 19 0 0
Page 5 Full wwPDB EM Validation Report EMD-7821, 6D6V
• Molecule 7 is a protein called Telomerase-associated protein 50.
Mol Chain Residues Atoms AltConf Trace
7 G 157 Total C N O785 471 157 157 0 0
• Molecule 8 is a protein called Telomerase associated protein p65.
Mol Chain Residues Atoms AltConf Trace
8 H 108 Total C N O S886 563 156 162 5 0 0
• Molecule 9 is ZINC ION (three-letter code: ZN) (formula: Zn).
Mol Chain Residues Atoms AltConf
9 D 1 Total Zn1 1 0
Page 6 Full wwPDB EM Validation Report EMD-7821, 6D6V
3 Residue-property plots i○
These plots are drawn for all protein, RNA, DNA and oligosaccharide chains in the entry. Thefirst graphic for a chain summarises the proportions of the various outlier classes displayed in thesecond graphic. The second graphic shows the sequence view annotated by issues in geometry andatom inclusion in map density. Residues are color-coded according to the number of geometricquality criteria for which they contain at least one outlier: green = 0, yellow = 1, orange = 2and red = 3 or more. A red diamond above a residue indicates a poor fit to the EM map forthis residue (all-atom inclusion < 40%). Stretches of 2 or more consecutive residues without anyoutlier are shown as a green connector. Residues present in the sample, but not in the model, areshown in grey.
• Molecule 1: Telomerase reverse transcriptase
Chain A:
MET
GLN
LYS
ILE
ASN
ASN
ILE
ASN
ASN
ASN
LYS
Q12
M13
L14
K17
E18
D19
L20
L21
T22
I27
S28
A29
L30
K31
Y32
V33
S34
N35
Q48
�T4
9S5
0�
E51
�L5
2�
D53
F56
Q57
E58
F59
T63
I64
I65
A66
S67
Y75
�K7
6Q7
7K7
8Y7
9�
N80
�Q8
1�
P82
�N8
3�
F84
�
S85
�Q8
6
D95
S96
L99
L100
K103
Q104
N105
Y106
V107
Q108
Q109
I110
T113
T114
I115
G116
V119
E120
Y121
E122
N123
I124
N125
L126
S127
R128
Q129
T130
L131
Y132
S133
S134
N135
F136
R137
N138
L139
L140
N141
I142
F143
G144
L156
V157
F158
T159
K160
V161
G165
Y166
L167
Q168
V169
A170
G171
V172
C173
L174
N175
F178
Q181
�VA
LLY
SGL
NLY
SLY
STR
PTY
RLY
SAS
NAS
NPH
EAS
NME
TAS
NGL
YLY
SAL
ATH
RSE
RAS
NAS
NAS
NGL
NAS
NAS
NAL
AAS
NLE
USE
RAS
NGL
ULY
SK2
14�
Q215
�E2
16N2
17�
Q218
�Y2
19
E223
�I2
24Q2
25R2
26
I229
F230
Y231
C232
N233
H234
M235
G236
�R2
37E2
38P2
39�
G240
�V2
41
N248
TYR
SER
GLU
ILE
LYS
LYS
GLY
PHE
GLN
PHE
LYS
VAL
ILE
GLN
GLU
LYS
LEU
GLN
GLY
ARG
GLN
PHE
ILE
ASN
SER
ASP
LYS
ILE
LYS
PRO
ASP
HIS
PRO
GLN
THR
ILE
ILE
LYS
LYS
THR
LEU
LEU
LYS
GLU
Y293
�
K296
�N2
97�
F298
�
S299
C300
E303
R304
D305
L306
F307
�L3
08E3
09F3
10
I314
V315
Q316
N317
N320
�
F323
L326
L327
K328
K329
F330
C331
K332
L333
P334
E335
�N3
36Y3
37
L340
K341
S342
Q343
I347
S350
�E3
51�
N352
�K3
53�
A354
�N3
55Q3
56Q3
57
E360
N361
L362
F363
�N3
64
F379
L380
I383
I384
C387
V388
P389
N390
Q391
L392
L393
G394
K395
K396
N397
F398
K399
V400
F401
K404
L405
Y406
Q410
M411
K412
E415
N416
Q417
K418
V419
L420
D421
Y422
I423
C424
D427
D430
W433
F434
V435
D436
Q440
T443
Q444
K445
R446
K447
Y448
K452
R453
K454
I455
D458
L459
I460
V461
F462
I463
K466
�I4
67
V471
L472
R473
Y474
N475
I478
T479
E480
K481
E484
R492
K493
P494
I495
W496
K497
S500
K501
L502
T503
I504
L507
E508
E509
GLU
ASN
LEU
GLU
LYS
VAL
GLU
GLU
LYS
LEU
ILE
PRO
GLU
ASP
SER
F525
�
Y528
P529
�Q5
30�
G531
K532
L533
R534
I535
I536
P537
K538
K539
G540
S541
F542
R543
P544
I545
M546
T547
F548
L549
R550
�K5
51�
D552
K553
Q554
K555
K558
L561
N562
Q563
I564
L565
M566
D567
S568
Q569
L570
V571
F572
R573
N574
L575
�K5
76D5
77�
M578
�L5
79�
G580
Q581
�K5
82�
I583
G584
Y585
�S5
86V5
87F5
88D5
89N5
90�
K591
Q592
I593
S594
F597
A598
Q599
K603
W604
�K6
05N6
06K6
07G6
08R6
09P6
10Q6
11L6
12Y6
13Y6
14V6
15T6
16L6
17D6
18I6
19K6
20K6
21�
C622
Y623
D624
S625
I626
D627
Q628
M629
K630
L631
L632
N633
F634
F635
N636
Q637
S638
D639
L640
I641
Q642
D643
T644
Y645
F646
I647
N648
K649
Y650
L651
L652
R655
N656
K657
Page 7 Full wwPDB EM Validation Report EMD-7821, 6D6V
R658
L661
�Q6
62�
I663
�Q6
64�
GLN
THR
ASN
ASN
LEU
ASN
SER
ALA
MET
GLU
ILE
GLU
GLU
GLU
LYS
ILE
ASN
LYS
LYS
PRO
PHE
LYS
MET
ASP
ASN
ILE
N691
F692
P693
Y694
Y695
F696
N697
L698
K699
E700
R701
�Q7
02I7
03A7
04Y7
05S7
06L7
07Y7
08
K720
�E7
21�
I722
Q723
S724
D725
D726
R727
P728
F729
I730
V731
Q734
�D7
35K7
36�
P737
R738
�C7
39I7
40T7
41K7
42
I745
H746
L749
K750
H751
I752
S753
Q754
Y755
�N7
56V7
57I7
58S7
59�
F760
N761
K762
V763
K764
F765
R766
Q767
K768
R769
G770
I771
P772
Q773
�G7
74L7
75N7
76I7
77
V780
F786
G787
K788
L789
E790
E791
T794
Q795
�F7
96L7
97
K798
N799
G805
L809
L810
M811
R812
D815
D816
Y817
L818
F819
D822
�S8
23Q8
24Q8
25N8
26A8
27L8
28N8
29L8
30I8
31V8
32Q8
33
G842
F845
Q848
�K8
49I8
50T8
51T8
52N8
53F8
54Q8
55�
F856
�P8
57Q8
58�
E859
D860
Y861
�N8
62L8
63�
E864
�H8
65�
F866
�K8
67�
I868
S869
V870
�Q8
71�
N872
�E8
73�
C874
I877
�G8
78�
K879
S880
I881
D882
M883
N884
T885
L886
E887
I888
K889
S890
I891
�Q8
92�
K893
Q894
T895
Q896
Q897
E898
I899
N900
�Q9
01�
N904
�V9
05A9
06I9
07S9
08I9
09K9
10N9
11L9
12K9
13S9
14Q9
15L9
16
K919
L920
R921
S922
L923
F924
L925
N926
Q927
L928
�
Y931
�F9
32�
N933
P934
N935
I936
�N9
37S9
38
F939
�E9
40�
G941
L942
C943
R944
�Q9
45L9
46Y9
47H9
48H9
49
T953
V954
F957
Y958
P959
F960
M961
T962
F965
L969
K970
K971
Y975
�
Y979
G980
K981
E982
N983
T984
N985
E986
N987
F988
L989
K990
D991
I992
L993
Y994
Y995
T996
V997
E998
D999
V100
0C1
001
K100
2I1
003
L100
4C1
005
Y100
6L1
007
Q100
8
F100
9�
E101
0�
D101
1�
E101
2
I101
7K1
018
E101
9I1
020
F102
1K1
022
N102
3
W102
7
W103
0�
D103
1I1
032
I103
3V1
034
S103
5Y1
036�
L103
7K1
038
K103
9K1
040
K104
1
K104
4G1
045
Y104
6L1
047
N104
8K1
049
L105
0L1
051
Q105
2K1
053
I105
4R1
055�
R105
8
K106
3
S106
8L1
069
Q107
0L1
071
I107
2�
L107
3�
S107
4Q1
075�
Q107
6�
K107
7�
Y107
8�
Q107
9L1
080�
N108
1K1
082
K108
3�
E108
4L1
085
E108
6
D109
2�
L109
3
I109
7�
Q109
8D1
099
I110
0K1
101�
T110
2L1
103
K110
6I1
107�
S110
8�
ALA
LYS
SER
ASN
GLN
GLN
ASN
THR
ASN
• Molecule 2: Telomerase-associated protein 82
Chain D:
MET
LYS
LEU
THR
LYS
GLY
GLY
SER
TYR
ILE
LEU
LYS
LYS
VAL
ASP
ARG
LYS
GLN
PHE
TYR
GLN
ASP
GLU
GLU
ILE
VAL
MET
GLN
ILE
LYS
LYS
ILE
LEU
GLY
GLN
LYS
THR
THR
ASP
CYS
LYS
GLN
TYR
ILE
LYS
CYS
GLU
CYS
ILE
ASP
GLY
LEU
GLY
ASP
GLU
ALA
LEU
ILE
TYR
PHE
GLU
MET
LEU
ALA
ASN
GLN
ASN
GLN
HIS
LEU
GLN
LYS
ASN
ASP
VAL
ILE
MET
ILE
GLN
ASP
TYR
LEU
ASN
ASP
LYS
THR
GLN
ASN
ASP
LYS
ILE
VAL
VAL
LEU
VAL
THR
ARG
PHE
GLN
PHE
CYS
LYS
ALA
SER
HIS
VAL
GLN
PRO
LYS
THR
ALA
GLN
LYS
GLU
SER
ILE
GLN
LEU
LEU
ASN
THR
GLU
LYS
THR
ILE
ILE
GLN
LYS
SER
LYS
ILE
THR
LYS
ASN
PRO
ALA
GLU
GLU
VAL
LEU
LYS
PHE
ILE
GLU
VAL
ASN
GLU
LYS
ASP
ASN
SER
SER
ASN
SER
GLU
ASP
MET
ILE
ILE
GLU
GLN
GLN
LYS
GLN
GLU
ILE
LYS
ASN
ASN
GLN
LYS
GLU
LYS
GLN
SER
ILE
ASN
GLY
PHE
ASN
LEU
GLU
ASP
SER
TYR
SER
ASN
ILE
SER
ASP
ILE
THR
ASN
PHE
GLY
GLY
LYS
SER
ASN
PHE
ASN
ILE
GLY
SER
LEU
SER
ASP
GLN
LEU
SER
LYS
GLN
THR
LEU
LEU
ILE
SER
GLN
LEU
GLN
VAL
GLY
LYS
ASN
ARG
PHE
SER
PHE
LYS
PHE
GLU
GLY
ARG
VAL
VAL
TYR
LYS
SER
SER
THR
PHE
GLN
ASN
GLN
GLN
ASP
SER
LYS
TYR
PHE
PHE
ILE
THR
ALA
GLN
ASP
ALA
ASN
ASN
GLN
GLU
ILE
ASN
LEU
SER
PHE
TRP
GLN
LYS
VAL
ASP
GLN
SER
TYR
GLN
THR
LEU
LYS
VAL
GLY
GLN
TYR
TYR
TYR
PHE
ILE
GLY
GLY
GLU
VAL
LYS
GLN
PHE
LYS
ASN
ASN
LEU
GLU
LEU
LYS
PHE
LYS
PHE
GLY
ASP
TYR
GLN
ILE
ILE
PRO
LYS
GLU
THR
LEU
SER
ALA
ASN
TYR
VAL
GLN
PRO
LEU
ALA
LEU
GLN
PRO
SER
LYS
GLN
PHE
GLY
ASN
ASP
SER
ILE
GLY
ASP
SER
ASP
TYR
SER
ILE
HIS
ASN
LEU
ILE
GLU
LYS
GLU
GLU
SER
ILE
ALA
GLN
LYS
GLY
TYR
ASN
GLY
GLN
LYS
ASN
ASN
LYS
TYR
ARG
GLN
ASN
ASN
ASN
ASN
SER
LYS
HIS
THR
LEU
LEU
ILE
SER
GLU
VAL
LEU
LYS
THR
SER
LYS
GLN
TYR
LEU
SER
VAL
LEU
ALA
GLN
VAL
VAL
ASP
ILE
GLN
SER
SER
ASP
LYS
ASN
ILE
ARG
LEU
LYS
ILE
CYS
ASP
ASN
SER
CYS
ASN
GLN
GLU
LEU
LYS
VAL
VAL
ILE
PHE
PRO
ASP
LEU
CYS
TYR
GLU
TRP
ARG
ASP
LYS
PHE
SER
ILE
ASN
LYS
TRP
TYR
TYR
PHE
ASN
GLU
PHE
VAL
ARG
GLN
ILE
TYR
ASN
ASP
GLU
VAL
GLN
LEU
LYS
ASN
ASN
ILE
HIS
SER
SER
ILE
LYS
GLU
SER
ASP
ASP
GLN
ARG
LYS
VAL
ILE
THR
TYR
ASN
GLN
GLU
GLN
Page 8 Full wwPDB EM Validation Report EMD-7821, 6D6V
GLY
VAL
PHE
LYS
LYS
SER
ILE
SER
ILE
ASN
SER
ASN
ASP
SER
PHE
GLU
ILE
LYS
PRO
LYS
ILE
SER
TYR
LYS
ASN
ASN
SER
ASN
GLN
GLU
Q511
�R5
12�
I513
�Y5
14S5
15S5
16I5
17E5
18
A524
S527
�E5
28I5
29
K533
E534
F535
Y536
V537
S543
I544
Q545
M546
K547
�
Y552
Y553
R554
C555
�T5
56�
C557
�Q5
58�
G559
�K5
60�
S561
V562
L563
�K5
64Y5
65H5
66�
G567
�D5
68�
S569
�F5
70F5
71�
C572
�E5
73�
S574
�C5
75�
Q576
�Q5
77F5
78I5
79�
N580
�P5
81Q5
82�
V583
H584
L585
M586
�L5
87R5
88A5
89F5
90V5
91Q5
92D5
93S5
94T5
95G5
96T5
97I5
98P5
99V6
00M6
01I6
02F6
03D6
04Q6
05Q6
06S6
07S6
08
I611
N612
S617
�
V620
Q621
�
Q625
Y626
V627
K628
N629
C630
I631
E636
I639
R640
Q641
L642
K645
L646
F651
I652
F653
E654
I655
Q656
F657
K660
E661
F662
N663
�N6
64E6
65�
I668
V672
L673
K674
I675
E676
E682
K685
Y686
L687
L688
K689
H693
L694
I695
ASN
ASN
ASN
GLN
ASN
ASN
• Molecule 3: Telomerase holoenzyme TEB heterotrimer Teb3 subunit
Chain F:
MET
ASP
ALA
GLU
GLN
E6 Y10
P11
R12
�I1
3�
L14
F15
M18
A19
Q20
F21
R22
�G2
3�
K24
�K2
5V2
6T2
7
C33
�N3
4�
E35
D36
�Q3
7�
N38
�D3
9S4
0L4
1�
V42
I43
E44
P47
�T4
8�
G49
�L5
0�
N51
Q52
H53
�V5
4V5
5I5
6D5
7N5
8�
Y59
�R6
0�
R61
�V6
2�
D63
L64
�N6
5�
N66
�
K69
F70
V71
R74
G75
�
L78
N79
�Q8
0�
N81
I82
C85
�E8
6�
E90
F91
�
K94
�
F97
D98
F99
�D1
00
K104
L105
I106
H107
�L1
08S1
09Q1
10S1
11D1
12K1
13L1
14S1
15�
S116
L117
F118
THR
ASP
GLN
• Molecule 4: Telomerase holoenzyme Teb2 subunit
Chain E:
MET
SER
ASN
ARG
VAL
GLN
GLY
GLY
PHE
ASP
ASN
ASN
SER
GLY
ASN
ASN
GLN
SER
ALA
GLN
LYS
GLN
GLN
ALA
GLU
LYS
ILE
PRO
Q29
�
C36
I39
N40
V43
K44
A45
A46
K47
E48
�
Q51
�A5
2�
H53
�S5
4�
G55
N56
�H5
7Y5
8E5
9W6
0Y6
1G6
2A6
3F6
4E6
5N6
6A6
7I6
8
I69
T70
F73
E74
�F7
5�
L76
Q77
�S7
8�
I79
�N8
0�
D81
�S8
2�
P83
K84
I85
M86
G87
K88
L89
S90
D91
G94
E97
�
I100
Q101
K102
�S1
03�
K104
�M1
05�
S106
D107
�E1
08L1
09�
P110
E111
Q114
E117
�I1
18
Q121
N122
N123
G124
N125
R126
H127
�K1
28Y1
29V1
30
M133
L134
K135
M136
R137
�K1
38N1
39A1
40�
Q141
I142
Q143
L144
�L1
45Y1
46F1
47S1
48I1
49V1
50
H159
R166
Y167
L168
Q169
R170
K171
H172
�G1
73�
I174
�E1
75�
D176
�F1
77�
MET
HIS
MET
THR
ASN
ASP
LYS
ALA
HIS
ASN
ASN
HIS
ASN
ALA
SER
ALA
GLN
LYS
VAL
HIS
TYR
GLN
ILE
ASP
ARG
ASN
GLN
GLN
PRO
LYS
GLU
GLN
VAL
LEU
GLU
LEU
MET
ARG
GLN
ILE
LEU
LYS
HIS
ASN
PRO
ASN
ASP
GLN
ILE
PRO
LYS
SER
LYS
ILE
ILE
GLU
PHE
PHE
GLN
SER
GLN
LEU
ASN
GLN
VAL
GLN
ILE
ASN
GLN
ILE
LEU
GLN
GLN
LEU
VAL
SER
ALA
ASN
GLU
ILE
PHE
SER
VAL
GLY
SER
ASP
ASN
TYR
LEU
LEU
ASN
VAL
• Molecule 5: RNA (159-MER)
Chain B:
Page 9 Full wwPDB EM Validation Report EMD-7821, 6D6V
A1�
U2�
A3�
C4�
C5 C6 G7 C8 U9 U10
A11�
A12�
U13�
U14�
C15
A16
U17
U18
C19
A20
G21
A22
U23
C24
U25
G26
U27
A28�
A29�
U30
A31
G32
A33
A34
C35
U36
G37
U38
C39
A40�
U41
U42�
C43�
A44
A45
C46
C47
C48
C49
A50
A51
A52
A53
A54
U55
C56�
U57
A58�
G59
U60
G61
C62
U63
�G6
4�
A65
U66
A67
U68
A69
A70
C71
C72
U73
U74
C75
A76
C77
C78
A79
A80
U81
U82
A83
G84
G85
U86
U87
C88
A89
�A9
0A9
1U9
2A9
3A9
4G9
5U9
6G9
7
A101
U102
G103
G106
G107
A108
�C1
09�
A110
�A1
11A1
12A1
13G1
14A1
15C1
16U1
17�
A118
U119
C120
G121
�A1
22�
C123
A124
U125
U126
U127
G128
A129
U130
A131
C132
A133
C134
U135
A136
U137
U138
U139
A140
U141
C142
A143
A144
U145
G146
G147
A148
U149
G150
U151
C152
U153
�U1
54A1
55�
U156
�U1
57�
U158
�U1
59�
• Molecule 6: DNA (5’-D(P*GP*TP*TP*GP*GP*GP*GP*TP*TP*GP*GP*GP*GP*TP*TP*GP*GP*GP*G)-3’)
Chain C:
G1�
T2 T3 G4 G5�
G6�
G7 T8 T9 G10�
G11
G12
G13
T14
T15
G16
G17
G18
G19
• Molecule 7: Telomerase-associated protein 50
Chain G:
X1 X2 X3 X8�
X9�
X10
�
X21
�
X26
�X2
7X2
8�
X29
�X3
0�
X31
�X3
2�
X33
�X3
4�
X35
�X3
6�
X37
X38
�
X47
X48
X49
X50
X51
X52
X53
X61
X62
X63
X64
�X6
5X6
6
X71
X72
X73
�X7
4X7
5�
X76
X77
X78
X84
X89
X90
�X9
1�
X92
�X9
3�
X94
X97
X98
�X9
9�
X100
X105
X106
X107
X108
�X1
09X1
10X1
11
X119
�X1
20X1
21X1
22�
X123
�X1
24�
X128
�
X132
�X1
33�
X134
X135
�X1
36�
X137
X138
�X1
39
X143
X149
�
X153
�
X156
�X1
57�
• Molecule 8: Telomerase associated protein p65
Chain H:
MET
ASP
GLU
TYR
LEU
GLU
ASN
THR
ASN
LEU
GLU
GLU
LEU
GLU
GLN
GLU
CYS
PHE
MET
GLU
ASP
TYR
GLN
HIS
GLU
ASP
VAL
VAL
GLU
GLN
GLU
ASN
HIS
GLN
VAL
ASP
ALA
ASN
ASP
ILE
TYR
GLU
ASN
GLN
GLN
MET
ASN
ASP
GLU
SER
GLN
LEU
ASN
GLN
ASP
VAL
LYS
ILE
SER
GLN
GLN
LYS
GLU
GLN
ALA
VAL
GLU
MET
ILE
GLU
GLU
GLN
GLN
GLN
ASN
ASN
GLN
ASP
LYS
PHE
LYS
GLN
PHE
GLN
ASP
CYS
MET
ALA
HIS
ILE
THR
GLU
LEU
ASN
PHE
LYS
ARG
ASN
TYR
GLN
ASN
LEU
THR
GLU
GLN
SER
SER
SER
ASN
ASN
VAL
VAL
ALA
GLU
GLU
LEU
ASP
ILE
LYS
GLU
SER
LEU
LYS
LEU
GLN
MET
GLU
TYR
TYR
PHE
CYS
ASP
THR
ASN
LEU
THR
HIS
ASP
SER
TYR
LEU
ARG
GLY
ILE
ILE
SER
LYS
SER
PRO
LYS
ASN
CYS
VAL
ASP
ILE
LYS
VAL
PHE
LEU
LYS
PHE
ASN
LYS
ILE
GLN
GLN
ILE
LEU
LYS
GLN
ILE
GLN
ASP
LYS
GLN
ILE
VAL
SER
THR
TYR
GLY
ILE
GLU
ASN
GLN
SER
GLN
LYS
LYS
ASN
HIS
LYS
ASN
TYR
LYS
ASN
GLN
ASN
ALA
THR
PHE
SER
LYS
LYS
ASP
LEU
ILE
HIS
LEU
ILE
ARG
ASP
SER
LEU
LYS
GLU
SER
LYS
ILE
LEU
LYS
VAL
LYS
MET
ASP
SER
LEU
LYS
VAL
LYS
ARG
ARG
PHE
PRO
PHE
ASN
LEU
GLU
GLN
ALA
LEU
LYS
ASN
SER
LYS
GLN
ARG
THR
LEU
TYR
ILE
ASP
PHE
LEU
PRO
PRO
LYS
CYS
SER
LYS
GLN
THR
LEU
VAL
SER
ILE
PHE
GLY
ASN
PHE
ARG
ILE
ILE
ASN
ILE
ASN
LEU
PRO
LEU
GLN
LYS
ASN
SER
GLN
LEU
CYS
GLN
GLY
PHE
ALA
PHE
ILE
GLU
PHE
PHE
SER
GLU
GLU
GLU
ALA
ASN
GLN
ALA
LEU
ILE
THR
LYS
ASN
SER
SER
ILE
PRO
LYS
GLU
LEU
ILE
LEU
LEU
THR
GLU
LYS
LYS
ILE
GLY
GLN
GLY
SER
ILE
ARG
ILE
ILE
THR
TYR
LYS
LYS
TRP
GLN
GLU
GLU
LYS
GLN
SER
PHE
LYS
GLU
LEU
SER
LYS
ASN
GLN
ASN
GLU
GLN
LYS
ASN
LYS
ASN
MET
ASN
GLN
Page 10 Full wwPDB EM Validation Report EMD-7821, 6D6V
SER
ARG
LYS
ALA
SER
ASP
GLU
PHE
VAL
SER
ILE
ASP
VAL
GLU
ILE
LYS
GLN
N378
�C3
79�
L380
�I3
81�
K382
�I3
83�
I384
�N3
85�
I386
�P3
87�
Q388
�G3
89�
T390
�L3
91�
K392
�A3
93�
E394
�V3
95�
V396
�L3
97�
A398
�V3
99�
R400
�H4
01�
L402
�G4
03�
Y404
�E4
05�
F406
�Y4
07�
C408
�D4
09�
Y410
�I4
11�
D412
�GL
UAS
NSE
RAS
NGL
NIL
EAS
NSE
R
ASN
LYS
ILE
SER
LEU
SER
THR
GLN
GLN
GLN
ASN
THR
ALA
GLN
CYS
SER
ASN
ILE
GLN
ILE
GLU
ASN
ASN
LEU
ILE
GLN
GLN
ASP
GLN
HIS
PRO
GLN
LEU
ASN
ASP
LEU
LEU
LYS
GLU
G460
�Q4
61�
A462
�M4
63�
I464
�R4
65�
F466
�Q4
67�
N468
�S4
69�
D470
�E4
71�
Q472
�R4
73�
L474
�A4
75�
I476
�Q4
77�
K478
�L4
79�
L480
�
N481
�H4
82�
N483
�N4
84�
N485
�K4
86�
L487
�Q4
88�
I489
�E4
90�
I491
�R4
92�
G493
�Q4
94�
I495
�C4
96�
D497
�V4
98�
I499
�S5
00�
T501
�I5
02�
P503
�E5
04�
D505
�E5
06�
E507
�K5
08�
N509
�Y5
10�
W511
�N5
12�
Y513
�I5
14�
K515
�F5
16�
K517
�K5
18�
N519
�E5
20�
F521
�R5
22�
K523
�F5
24�
F525
�F5
26�
M527
�K5
28�
K529
�Q5
30�
Q531
�K5
32�
LYS
GLN
ASN
ILE
THR
GLN
ASN
TYR
ASN
LYS
Page 11 Full wwPDB EM Validation Report EMD-7821, 6D6V
4 Experimental information i○
Property Value SourceEM reconstruction method SINGLE PARTICLE DepositorImposed symmetry POINT, Not providedNumber of particles used 52506 DepositorResolution determination method FSC 0.143 CUT-OFF DepositorCTF correction method PHASE FLIPPING AND AMPLITUDE
CORRECTIONDepositor
Microscope FEI TITAN KRIOS DepositorVoltage (kV) 300 DepositorElectron dose (e−/Å2
) 52 DepositorMinimum defocus (nm) Not providedMaximum defocus (nm) Not providedMagnification Not providedImage detector GATAN K2 QUANTUM (4k x 4k) DepositorMaximum map value 0.156 DepositorMinimum map value -0.054 DepositorAverage map value -0.000 DepositorMap value standard deviation 0.006 DepositorRecommended contour level 0.055 DepositorMap size (Å) 348.16, 348.16, 348.16 wwPDBMap dimensions 256, 256, 256 wwPDBMap angles (◦) 90.0, 90.0, 90.0 wwPDBPixel spacing (Å) 1.36, 1.36, 1.36 Depositor
Page 12 Full wwPDB EM Validation Report EMD-7821, 6D6V
5 Model quality i○
5.1 Standard geometry i○
Bond lengths and bond angles in the following residue types are not validated in this section:ZN
The Z score for a bond length (or angle) is the number of standard deviations the observed valueis removed from the expected value. A bond length (or angle) with |Z| > 5 is considered anoutlier worth inspection. RMSZ is the root-mean-square of all Z scores of the bond lengths (orangles).
Mol Chain Bond lengths Bond anglesRMSZ #|Z| >5 RMSZ #|Z| >5
1 A 0.73 1/8418 (0.0%) 0.89 16/11318 (0.1%)2 D 0.69 0/1566 0.77 1/2101 (0.0%)3 F 0.59 0/934 0.73 0/12624 E 0.64 0/1230 0.82 1/1655 (0.1%)5 B 1.13 9/3711 (0.2%) 2.03 208/5768 (3.6%)6 C 1.56 2/456 (0.4%) 1.49 10/707 (1.4%)8 H 0.31 1/899 (0.1%) 0.35 0/1205All All 0.84 13/17214 (0.1%) 1.25 236/24016 (1.0%)
Chiral center outliers are detected by calculating the chiral volume of a chiral center and verifying ifthe center is modelled as a planar moiety or with the opposite hand.A planarity outlier is detectedby checking planarity of atoms in a peptide group, atoms in a mainchain group or atoms of asidechain that are expected to be planar.
Mol Chain #Chirality outliers #Planarity outliers1 A 0 253 F 0 44 E 0 57 G 0 6All All 0 40
All (13) bond length outliers are listed below:
Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)5 B 44 A N9-C4 -6.88 1.33 1.376 C 9 DT C3’-O3’ 6.75 1.52 1.445 B 33 A N9-C4 -6.42 1.33 1.375 B 47 C N1-C6 -6.41 1.33 1.375 B 69 A N9-C4 -6.27 1.34 1.376 C 15 DT C3’-O3’ -5.76 1.36 1.448 H 527 MET CG-SD 5.68 1.96 1.81
Continued on next page...
Page 13 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)5 B 22 A N9-C4 -5.67 1.34 1.375 B 49 C C4-C5 -5.61 1.38 1.435 B 49 C C5-C6 -5.52 1.29 1.345 B 29 A N9-C4 5.49 1.41 1.371 A 120 GLU CB-CG 5.37 1.62 1.525 B 148 A N7-C5 -5.10 1.36 1.39
All (236) bond angle outliers are listed below:
Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 B 46 C O4’-C1’-N1 22.24 125.99 108.205 B 47 C C5-C6-N1 16.33 129.16 121.005 B 47 C C6-N1-C2 -14.86 114.36 120.305 B 48 C C5-C6-N1 14.04 128.02 121.005 B 145 U N1-C2-O2 13.35 132.15 122.805 B 49 C C2-N1-C1’ 13.19 133.30 118.805 B 25 U C2-N1-C1’ 12.88 133.15 117.705 B 120 C N1-C2-O2 12.79 126.57 118.905 B 145 U N3-C2-O2 -12.34 113.56 122.205 B 17 U N3-C2-O2 -12.03 113.78 122.205 B 49 C C5-C4-N4 -11.96 111.82 120.205 B 145 U C2-N1-C1’ 11.82 131.88 117.705 B 53 A O5’-P-OP2 -11.63 95.24 105.705 B 48 C C6-N1-C2 -11.54 115.68 120.305 B 49 C C5-C6-N1 11.23 126.62 121.005 B 25 U N1-C2-O2 10.72 130.31 122.805 B 123 C N1-C2-O2 10.68 125.31 118.905 B 17 U N1-C2-O2 10.61 130.22 122.805 B 49 C C6-N1-C1’ -10.52 108.17 120.805 B 112 A N1-C6-N6 10.43 124.86 118.605 B 120 C N3-C2-O2 -9.73 115.09 121.905 B 82 U N3-C2-O2 -9.71 115.40 122.205 B 102 U C5-C6-N1 9.36 127.38 122.705 B 145 U C6-N1-C1’ -9.30 108.18 121.205 B 25 U C6-N1-C1’ -9.21 108.31 121.205 B 35 C N1-C2-O2 9.20 124.42 118.906 C 14 DT O4’-C1’-N1 9.20 114.44 108.005 B 148 A C6-C5-N7 -9.12 125.91 132.305 B 70 A N9-C4-C5 -9.03 102.19 105.805 B 152 C C5-C6-N1 9.01 125.50 121.005 B 88 C N3-C4-C5 8.85 125.44 121.905 B 123 C N3-C2-O2 -8.72 115.79 121.90
Continued on next page...
Page 14 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 B 49 C N3-C4-N4 8.70 124.09 118.005 B 81 U N3-C2-O2 -8.64 116.15 122.205 B 33 A O4’-C1’-N9 8.58 115.06 108.205 B 120 C C2-N1-C1’ 8.56 128.22 118.805 B 25 U N3-C2-O2 -8.51 116.24 122.205 B 137 U N1-C2-O2 8.47 128.73 122.805 B 137 U C2-N1-C1’ 8.41 127.80 117.705 B 82 U N1-C2-O2 8.22 128.56 122.805 B 84 G N7-C8-N9 8.08 117.14 113.101 A 651 LEU CA-CB-CG 8.06 133.84 115.305 B 3 A P-O3’-C3’ 8.04 129.34 119.705 B 69 A N3-C4-N9 -7.96 121.03 127.405 B 85 G N7-C8-N9 7.90 117.05 113.105 B 52 A C2-N3-C4 7.89 114.54 110.605 B 118 A O5’-P-OP1 -7.83 98.65 105.701 A 830 LEU CA-CB-CG 7.78 133.19 115.305 B 103 G C4-C5-N7 7.75 113.90 110.805 B 35 C N3-C2-O2 -7.73 116.49 121.905 B 150 G N7-C8-N9 7.71 116.95 113.105 B 49 C N1-C2-O2 7.67 123.50 118.905 B 33 A C8-N9-C1’ 7.66 141.49 127.705 B 6 C C5-C6-N1 7.65 124.82 121.005 B 17 U C2-N1-C1’ 7.55 126.76 117.705 B 81 U N1-C2-O2 7.53 128.07 122.805 B 8 C C5-C6-N1 7.51 124.76 121.005 B 137 U N3-C2-O2 -7.46 116.98 122.205 B 69 A C6-C5-N7 7.43 137.50 132.305 B 52 A N3-C4-N9 7.34 133.28 127.405 B 33 A C4-N9-C1’ -7.30 113.17 126.305 B 47 C O4’-C1’-N1 7.23 113.98 108.205 B 114 G C4-C5-N7 7.20 113.68 110.805 B 57 U C2-N1-C1’ 7.15 126.28 117.705 B 57 U N1-C2-O2 7.13 127.79 122.805 B 120 C C6-N1-C1’ -7.12 112.26 120.805 B 48 C C4-C5-C6 -7.09 113.86 117.405 B 148 A C4-C5-N7 7.04 114.22 110.705 B 46 C P-O5’-C5’ 7.02 132.14 120.905 B 112 A C5-C6-N6 -7.01 118.09 123.705 B 112 A C4-C5-N7 6.99 114.19 110.705 B 69 A N1-C2-N3 6.97 132.78 129.305 B 96 U N3-C2-O2 -6.96 117.32 122.205 B 84 G C5-N7-C8 -6.96 100.82 104.30
Continued on next page...
Page 15 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 B 70 A C4-C5-N7 6.89 114.14 110.705 B 103 G C5-N7-C8 -6.88 100.86 104.301 A 922 SER C-N-CA 6.79 138.67 121.705 B 62 C N3-C2-O2 -6.78 117.16 121.905 B 49 C C4-C5-C6 -6.74 114.03 117.405 B 33 A N3-C4-N9 -6.73 122.02 127.405 B 123 C C5-C6-N1 6.71 124.35 121.005 B 85 G C5-N7-C8 -6.67 100.97 104.305 B 95 G N3-C4-N9 6.66 130.00 126.006 C 1 DG P-O3’-C3’ 6.65 127.67 119.705 B 114 G C5-N7-C8 -6.60 101.00 104.305 B 53 A N9-C4-C5 6.60 108.44 105.805 B 69 A C4-N9-C1’ -6.59 114.43 126.305 B 73 U N3-C2-O2 -6.59 117.58 122.205 B 73 U N1-C2-O2 6.57 127.40 122.805 B 47 C N3-C4-N4 6.57 122.60 118.005 B 88 C C6-N1-C2 6.57 122.93 120.305 B 18 U N1-C2-O2 6.56 127.39 122.805 B 69 A C2-N3-C4 -6.56 107.32 110.605 B 8 C N1-C2-O2 6.54 122.83 118.905 B 70 A N1-C6-N6 6.54 122.52 118.605 B 80 A N1-C2-N3 -6.51 126.05 129.305 B 134 C N1-C2-O2 6.51 122.80 118.905 B 150 G C5-N7-C8 -6.45 101.08 104.305 B 148 A N9-C4-C5 -6.45 103.22 105.805 B 25 U C5-C6-N1 6.40 125.90 122.705 B 83 A N7-C8-N9 6.37 116.98 113.805 B 47 C C2-N3-C4 6.35 123.08 119.905 B 54 A O5’-P-OP1 -6.34 100.00 105.705 B 148 A N1-C6-N6 6.27 122.36 118.605 B 148 A N7-C8-N9 6.27 116.94 113.805 B 57 U C6-N1-C1’ -6.26 112.43 121.205 B 41 U OP1-P-O3’ 6.19 118.82 105.205 B 8 C C2-N1-C1’ 6.16 125.58 118.805 B 42 U C6-N1-C2 -6.15 117.31 121.005 B 77 C N1-C2-O2 6.13 122.58 118.905 B 69 A C8-N9-C1’ 6.11 138.70 127.705 B 29 A C2-N3-C4 6.10 113.65 110.605 B 123 C C6-N1-C2 -6.07 117.87 120.305 B 69 A C4-C5-C6 -6.05 113.98 117.005 B 152 C C4-C5-C6 -6.04 114.38 117.406 C 1 DG OP2-P-O3’ 5.99 118.38 105.20
Continued on next page...
Page 16 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 B 62 C N1-C2-O2 5.98 122.49 118.905 B 137 U C6-N1-C1’ -5.97 112.83 121.201 A 989 LEU CA-CB-CG -5.95 101.62 115.305 B 73 U C5-C6-N1 5.93 125.67 122.705 B 103 G N7-C8-N9 5.88 116.04 113.105 B 111 A C6-N1-C2 5.88 122.13 118.605 B 69 A N3-C4-C5 5.86 130.90 126.805 B 94 A N1-C2-N3 -5.86 126.37 129.305 B 114 G N1-C6-O6 5.86 123.41 119.905 B 46 C C6-N1-C2 5.85 122.64 120.305 B 20 A N9-C4-C5 -5.83 103.47 105.805 B 77 C C5-C6-N1 5.82 123.91 121.005 B 124 A C8-N9-C4 -5.81 103.47 105.805 B 42 U C5-C6-N1 5.79 125.60 122.705 B 112 A C5-N7-C8 -5.77 101.02 103.905 B 36 U N3-C2-O2 -5.75 118.17 122.205 B 112 A N9-C4-C5 -5.75 103.50 105.806 C 14 DT C1’-O4’-C4’ -5.74 104.36 110.106 C 9 DT P-O3’-C3’ 5.73 126.58 119.705 B 33 A P-O3’-C3’ 5.72 126.57 119.701 A 507 LEU CA-CB-CG 5.71 128.44 115.306 C 2 DT O4’-C4’-C3’ -5.70 102.22 104.505 B 8 C C6-N1-C2 -5.69 118.02 120.305 B 46 C C1’-O4’-C4’ -5.69 105.35 109.905 B 29 A N3-C4-N9 5.68 131.95 127.401 A 731 VAL CG1-CB-CG2 -5.67 101.82 110.905 B 114 G N7-C8-N9 5.66 115.93 113.105 B 103 G N1-C6-O6 5.65 123.29 119.902 D 646 LEU CA-CB-CG -5.65 102.31 115.305 B 148 A C4-C5-C6 5.64 119.82 117.005 B 69 A N9-C4-C5 5.64 108.06 105.801 A 1050 LEU CA-CB-CG -5.63 102.34 115.305 B 96 U C6-N1-C2 -5.63 117.62 121.005 B 148 A N3-C4-N9 5.61 131.89 127.405 B 136 A P-O3’-C3’ 5.61 126.43 119.701 A 703 ILE CG1-CB-CG2 -5.60 99.08 111.405 B 22 A N3-C4-N9 -5.60 122.92 127.401 A 658 ARG NE-CZ-NH2 -5.59 117.51 120.304 E 140 ALA N-CA-CB -5.57 102.30 110.105 B 83 A C8-N9-C4 -5.57 103.57 105.805 B 20 A N1-C2-N3 -5.56 126.52 129.305 B 77 C C6-N1-C2 -5.55 118.08 120.30
Continued on next page...
Page 17 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 B 137 U P-O3’-C3’ 5.53 126.33 119.705 B 148 A C5-N7-C8 -5.53 101.14 103.905 B 52 A N9-C4-C5 -5.52 103.59 105.805 B 29 A C4-N9-C1’ 5.51 136.22 126.301 A 627 ASP N-CA-C -5.50 96.14 111.006 C 7 DG O4’-C1’-N9 5.50 111.85 108.001 A 707 LEU CA-CB-CG 5.49 127.93 115.305 B 20 A C4-C5-N7 5.49 113.45 110.705 B 136 A OP2-P-O3’ 5.47 117.24 105.205 B 113 A N7-C8-N9 5.47 116.54 113.805 B 60 U P-O3’-C3’ 5.47 126.26 119.705 B 86 U N3-C2-O2 -5.47 118.37 122.205 B 22 A C2-N3-C4 -5.46 107.87 110.605 B 47 C N3-C4-C5 -5.45 119.72 121.901 A 570 LEU CA-CB-CG -5.45 102.76 115.305 B 88 C O4’-C1’-N1 5.45 112.56 108.205 B 9 U N1-C2-O2 5.43 126.60 122.805 B 42 U O4’-C1’-N1 5.43 112.54 108.205 B 9 U C5-C6-N1 5.42 125.41 122.705 B 47 C C4-C5-C6 -5.42 114.69 117.405 B 152 C C5-C4-N4 -5.40 116.42 120.205 B 49 C N3-C4-C5 5.40 124.06 121.905 B 57 U N3-C2-O2 -5.40 118.42 122.205 B 33 A C4-C5-C6 -5.39 114.30 117.005 B 59 G P-O3’-C3’ 5.38 126.16 119.705 B 95 G C8-N9-C1’ -5.38 120.00 127.005 B 33 A N3-C4-C5 5.38 130.57 126.805 B 75 C N1-C2-O2 5.37 122.12 118.905 B 58 A O4’-C1’-N9 5.37 112.50 108.201 A 585 TYR CA-CB-CG 5.35 123.56 113.405 B 112 A C6-C5-N7 -5.34 128.56 132.305 B 113 A N1-C6-N6 5.34 121.80 118.605 B 29 A N7-C8-N9 5.30 116.45 113.805 B 53 A N3-C4-N9 -5.30 123.16 127.405 B 44 A C2-N3-C4 -5.30 107.95 110.601 A 590 ASN C-N-CA 5.30 134.94 121.705 B 78 C C5-C6-N1 5.29 123.65 121.005 B 103 G C6-C5-N7 -5.29 127.22 130.405 B 152 C C6-N1-C2 -5.29 118.18 120.305 B 114 G C6-C5-N7 -5.29 127.23 130.405 B 70 A C5-N7-C8 -5.29 101.26 103.905 B 59 G N3-C4-N9 5.28 129.17 126.00
Continued on next page...
Page 18 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 B 85 G C6-C5-N7 -5.28 127.23 130.405 B 85 G C4-C5-N7 5.28 112.91 110.805 B 52 A N3-C4-C5 -5.27 123.11 126.805 B 49 C C6-N1-C2 -5.26 118.20 120.305 B 42 U C6-N1-C1’ 5.25 128.54 121.205 B 66 U O5’-P-OP1 -5.23 100.99 105.705 B 29 A N3-C4-C5 -5.18 123.17 126.806 C 11 DG OP2-P-O3’ 5.18 116.60 105.206 C 15 DT N3-C4-O4 5.18 123.01 119.905 B 18 U N3-C2-O2 -5.17 118.58 122.201 A 593 ILE CG1-CB-CG2 -5.17 100.02 111.405 B 41 U P-O3’-C3’ 5.17 125.90 119.705 B 138 U O4’-C1’-N1 5.16 112.33 108.205 B 80 A C6-N1-C2 5.15 121.69 118.605 B 84 G C4-C5-N7 5.14 112.86 110.805 B 52 A N1-C2-N3 -5.14 126.73 129.305 B 44 A N3-C4-N9 -5.12 123.30 127.405 B 132 C C2-N1-C1’ 5.12 124.43 118.805 B 69 A N1-C6-N6 -5.12 115.53 118.605 B 124 A N7-C8-N9 5.11 116.36 113.805 B 73 U C2-N1-C1’ 5.11 123.83 117.706 C 10 DG P-O3’-C3’ 5.10 125.81 119.705 B 6 C C2-N3-C4 5.08 122.44 119.901 A 20 LEU CA-CB-CG -5.07 103.64 115.305 B 62 C O4’-C1’-N1 5.07 112.25 108.205 B 129 A N9-C4-C5 -5.07 103.77 105.805 B 37 G N3-C4-C5 5.06 131.13 128.605 B 84 G C6-C5-N7 -5.04 127.38 130.405 B 24 C N1-C2-O2 5.03 121.92 118.905 B 53 A C8-N9-C1’ 5.02 136.74 127.705 B 83 A C5-N7-C8 -5.02 101.39 103.905 B 29 A C8-N9-C4 -5.02 103.79 105.805 B 62 C OP2-P-O3’ 5.02 116.24 105.205 B 44 A N3-C4-C5 5.01 130.31 126.805 B 20 A C5-C6-N1 5.01 120.20 117.705 B 42 U C2’-C3’-O3’ 5.00 121.70 113.70
There are no chirality outliers.
All (40) planarity outliers are listed below:
Mol Chain Res Type Group1 A 1004 LEU Peptide
Continued on next page...
Page 19 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type Group1 A 1007 LEU Peptide1 A 122 GLU Peptide1 A 144 GLY Peptide1 A 17 LYS Peptide1 A 217 ASN Peptide1 A 233 ASN Peptide1 A 238 GLU Peptide1 A 240 GLY Peptide1 A 299 SER Peptide1 A 300 CYS Peptide1 A 548 PHE Peptide1 A 584 GLY Peptide1 A 698 LEU Peptide1 A 724 SER Peptide1 A 725 ASP Peptide1 A 760 PHE Peptide1 A 805 GLY Peptide1 A 84 PHE Peptide1 A 851 THR Peptide1 A 853 ASN Peptide1 A 865 HIS Peptide1 A 924 PHE Peptide1 A 933 ASN Peptide1 A 936 ILE Peptide4 E 122 ASN Peptide4 E 123 ASN Peptide4 E 125 ASN Peptide4 E 61 TYR Peptide4 E 81 ASP Peptide3 F 21 PHE Peptide3 F 58 ASN Peptide3 F 65 ASN Peptide3 F 97 PHE Peptide7 G 108 UNK Peptide7 G 109 UNK Peptide7 G 110 UNK Peptide7 G 136 UNK Peptide7 G 62 UNK Peptide7 G 66 UNK Peptide
Page 20 Full wwPDB EM Validation Report EMD-7821, 6D6V
5.2 Too-close contacts i○
In the following table, the Non-H and H(model) columns list the number of non-hydrogen atomsand hydrogen atoms in the chain respectively. The H(added) column lists the number of hydrogenatoms added and optimized by MolProbity. The Clashes column lists the number of clashes withinthe asymmetric unit, whereas Symm-Clashes lists symmetry-related clashes.
Mol Chain Non-H H(model) H(added) Clashes Symm-Clashes1 A 8253 0 8327 437 02 D 1538 0 1524 76 03 F 919 0 898 36 04 E 1207 0 1198 75 05 B 3322 0 1686 140 06 C 406 0 216 16 07 G 785 0 177 42 08 H 886 0 880 73 09 D 1 0 0 0 0All All 17317 0 14906 795 0
The all-atom clashscore is defined as the number of clashes found per 1000 atoms (includinghydrogen atoms). The all-atom clashscore for this structure is 26.
All (795) close contacts within the same asymmetric unit are listed below, sorted by their clashmagnitude.
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
7:G:98:UNK:HA 7:G:123:UNK:CB 1.28 1.601:A:530:GLN:HG2 1:A:757:VAL:CG1 1.13 1.597:G:75:UNK:HA 7:G:110:UNK:CB 1.37 1.547:G:51:UNK:CB 7:G:73:UNK:O 1.64 1.457:G:50:UNK:O 7:G:74:UNK:CB 1.69 1.388:H:412:ASP:C 8:H:460:GLY:HA3 1.46 1.357:G:51:UNK:HA 7:G:74:UNK:CB 1.57 1.331:A:530:GLN:CG 1:A:757:VAL:CG1 2.07 1.324:E:140:ALA:O 4:E:141:GLN:HG2 1.28 1.315:B:122:A:N7 8:H:518:LYS:HD2 1.45 1.295:B:121:G:P 8:H:518:LYS:HA 1.72 1.27
7:G:51:UNK:CA 7:G:74:UNK:CB 2.19 1.215:B:140:A:H5’ 8:H:396:VAL:CG1 1.74 1.167:G:50:UNK:C 7:G:74:UNK:CB 2.24 1.157:G:98:UNK:CA 7:G:123:UNK:CB 2.24 1.157:G:75:UNK:CA 7:G:110:UNK:CB 2.23 1.155:B:121:G:OP1 8:H:518:LYS:HA 1.45 1.141:A:626:ILE:CG1 1:A:770:GLY:HA2 1.76 1.14
Continued on next page...
Page 21 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
5:B:122:A:N7 8:H:518:LYS:CD 2.10 1.145:B:122:A:C8 8:H:518:LYS:HG2 1.85 1.11
4:E:135:LYS:HE2 4:E:137:ARG:HD3 1.22 1.114:E:65:GLU:OE2 4:E:136:MET:O 1.67 1.104:E:46:ALA:HB1 4:E:138:LYS:HE3 1.31 1.105:B:140:A:C5’ 8:H:396:VAL:HG11 1.81 1.104:E:140:ALA:O 4:E:141:GLN:CG 1.98 1.09
1:A:530:GLN:HG2 1:A:757:VAL:HG12 1.16 1.085:B:140:A:H5’ 8:H:396:VAL:HG11 1.34 1.08
4:E:135:LYS:HE2 4:E:137:ARG:CD 1.83 1.071:A:529:PRO:CB 1:A:554:GLN:HG2 1.83 1.075:B:121:G:C1’ 8:H:517:LYS:HA 1.86 1.064:E:135:LYS:CE 4:E:137:ARG:HD3 1.86 1.054:E:58:TYR:HE2 4:E:136:MET:HG2 1.16 1.051:A:530:GLN:CG 1:A:757:VAL:HG12 1.76 1.047:G:47:UNK:O 7:G:77:UNK:O 1.76 1.04
1:A:626:ILE:HG12 1:A:770:GLY:HA2 1.33 1.035:B:121:G:C1’ 8:H:520:GLU:HB3 1.89 1.02
1:A:529:PRO:HA 1:A:554:GLN:HE21 1.23 1.021:A:530:GLN:HG2 1:A:757:VAL:HG13 1.03 1.001:A:824:GLN:O 1:A:828:LEU:HB2 1.62 1.005:B:121:G:OP1 8:H:518:LYS:CA 2.10 1.005:B:122:A:N7 8:H:518:LYS:CG 2.26 0.995:B:121:G:C1’ 8:H:517:LYS:CA 2.40 0.991:A:593:ILE:O 1:A:597:PHE:HB3 1.63 0.985:B:146:G:O2’ 8:H:528:LYS:HE3 1.63 0.981:A:912:LEU:O 1:A:916:LEU:HB2 1.63 0.987:G:51:UNK:CA 7:G:73:UNK:O 2.12 0.984:E:58:TYR:CE2 4:E:136:MET:HG2 2.01 0.95
5:B:121:G:P 8:H:518:LYS:CA 2.53 0.951:A:530:GLN:HG2 1:A:757:VAL:HG11 1.48 0.947:G:51:UNK:CB 7:G:73:UNK:C 2.44 0.947:G:97:UNK:O 7:G:123:UNK:CB 2.17 0.92
2:D:577:GLN:OE1 2:D:579:ILE:HB 1.69 0.911:A:626:ILE:HB 1:A:770:GLY:N 1.86 0.905:B:140:A:H5’ 8:H:396:VAL:HG12 1.52 0.89
1:A:529:PRO:HB2 1:A:554:GLN:HG2 1.53 0.891:A:626:ILE:HG13 1:A:771:ILE:HG12 1.54 0.881:A:626:ILE:CD1 1:A:771:ILE:HG12 2.04 0.885:B:121:G:OP1 8:H:518:LYS:CB 2.23 0.867:G:51:UNK:HA 7:G:73:UNK:C 2.06 0.86
Continued on next page...
Page 22 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
5:B:122:A:C8 8:H:518:LYS:CG 2.58 0.861:A:530:GLN:CG 1:A:757:VAL:HG13 1.87 0.854:E:140:ALA:C 4:E:141:GLN:HG2 1.97 0.851:A:787:GLY:O 1:A:791:GLU:HB2 1.76 0.85
1:A:658:ARG:HH22 1:A:697:ASN:HB2 1.42 0.848:H:412:ASP:C 8:H:460:GLY:CA 2.40 0.831:A:462:PHE:O 1:A:466:LYS:HB2 1.79 0.821:A:1017:ILE:O 1:A:1021:PHE:HB2 1.81 0.811:A:626:ILE:CG1 1:A:771:ILE:HG12 2.10 0.811:A:984:THR:O 1:A:988:PHE:HB3 1.81 0.807:G:75:UNK:CB 7:G:110:UNK:C 2.58 0.801:A:529:PRO:CA 1:A:554:GLN:HG2 2.11 0.807:G:51:UNK:N 7:G:74:UNK:CB 2.45 0.805:B:122:A:H2 8:H:407:TYR:CG 2.00 0.795:B:117:U:C1’ 8:H:526:PHE:HB2 2.12 0.79
2:D:572:CYS:SG 2:D:579:ILE:HB 2.23 0.795:B:120:C:C4 8:H:522:ARG:HA 2.18 0.79
4:E:136:MET:HG3 4:E:142:ILE:HD11 1.65 0.797:G:75:UNK:CB 7:G:110:UNK:O 2.32 0.785:B:86:U:O2 5:B:88:C:N4 2.17 0.77
1:A:626:ILE:CG1 1:A:770:GLY:CA 2.60 0.771:A:582:LYS:HA 1:A:787:GLY:HA2 1.67 0.764:E:39:ILE:HD11 4:E:136:MET:CE 2.15 0.765:B:117:U:O4’ 8:H:526:PHE:HD2 1.69 0.76
4:E:39:ILE:HD11 4:E:136:MET:HE3 1.67 0.757:G:51:UNK:HA 7:G:74:UNK:CA 2.16 0.751:A:549:LEU:O 1:A:554:GLN:OE1 2.04 0.754:E:59:GLU:HA 4:E:63:ALA:HA 1.70 0.745:B:128:G:N2 5:B:142:C:O2 2.18 0.745:B:140:A:O2’ 8:H:393:ALA:HA 1.88 0.73
1:A:530:GLN:HG3 1:A:757:VAL:HG12 1.68 0.733:F:42:VAL:HG13 3:F:58:ASN:HD21 1.53 0.735:B:121:G:OP1 8:H:518:LYS:HG2 1.88 0.734:E:135:LYS:NZ 4:E:137:ARG:HD3 2.03 0.73
1:A:651:LEU:HD23 1:A:700:GLU:HB3 1.71 0.735:B:121:G:OP2 8:H:521:PHE:CB 2.34 0.73
1:A:766:ARG:HH22 1:A:772:PRO:HD3 1.54 0.721:A:529:PRO:CA 1:A:554:GLN:HE21 1.99 0.721:A:529:PRO:HA 1:A:554:GLN:NE2 2.01 0.721:A:617:LEU:HB3 1:A:817:TYR:HB3 1.73 0.711:A:889:LYS:HA 1:A:945:GLN:HE22 1.54 0.71
Continued on next page...
Page 23 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
5:B:141:U:H4’ 8:H:392:LYS:HD3 1.73 0.703:F:33:CYS:H 3:F:44:GLU:HA 1.54 0.707:G:74:UNK:O 7:G:111:UNK:N 2.25 0.705:B:128:G:N1 5:B:142:C:N3 2.36 0.70
1:A:103:LYS:HG3 2:D:640:ARG:HH22 1.56 0.705:B:122:A:C8 8:H:518:LYS:CD 2.75 0.69
1:A:558:LYS:HA 1:A:561:LEU:HD12 1.75 0.695:B:94:A:H3’ 5:B:95:G:H21 1.57 0.69
2:D:572:CYS:SG 2:D:579:ILE:CG2 2.80 0.694:E:135:LYS:HE2 4:E:137:ARG:CG 2.23 0.694:E:46:ALA:CB 4:E:138:LYS:HE3 2.18 0.685:B:70:A:H2 5:B:88:C:H41 1.40 0.68
1:A:630:LYS:O 1:A:788:LYS:NZ 2.25 0.685:B:121:G:H2’ 8:H:517:LYS:HB3 1.76 0.688:H:412:ASP:O 8:H:460:GLY:HA3 1.93 0.681:A:626:ILE:CB 1:A:770:GLY:HA2 2.23 0.685:B:43:C:H4’ 5:B:44:A:H5’ 1.74 0.675:B:122:A:C2 8:H:407:TYR:CG 2.82 0.67
1:A:790:GLU:OE2 1:A:812:ARG:NH1 2.26 0.671:A:944:ARG:O 1:A:948:HIS:HB2 1.93 0.674:E:56:ASN:HA 4:E:138:LYS:HB2 1.76 0.675:B:140:A:C4’ 8:H:396:VAL:HG11 2.25 0.67
2:D:514:TYR:HA 2:D:536:TYR:HB3 1.77 0.673:F:14:LEU:HD21 3:F:47:PRO:HD2 1.77 0.671:A:528:TYR:HB3 1:A:530:GLN:NE2 2.09 0.661:A:643:ASP:H 1:A:740:ILE:HA 1.59 0.665:B:149:U:H2’ 5:B:150:G:H8 1.60 0.665:B:121:G:OP1 8:H:518:LYS:CG 2.42 0.66
2:D:612:ASN:HD22 2:D:620:VAL:HG13 1.59 0.661:A:615:VAL:HB 1:A:819:PHE:HB2 1.77 0.661:A:923:LEU:HA 1:A:927:GLN:HE21 1.61 0.667:G:75:UNK:CB 7:G:110:UNK:CB 2.73 0.661:A:1051:LEU:HA 1:A:1054:ILE:HD12 1.77 0.667:G:100:UNK:HA 7:G:121:UNK:CB 2.26 0.665:B:140:A:C5’ 8:H:396:VAL:CG1 2.52 0.65
2:D:564:LYS:HB3 6:C:6:DG:H4’ 1.78 0.654:E:140:ALA:O 4:E:141:GLN:CB 2.44 0.651:A:626:ILE:HB 1:A:770:GLY:CA 2.26 0.651:A:481:LYS:HB3 1:A:484:GLU:HB2 1.79 0.655:B:121:G:O4’ 8:H:521:PHE:N 2.29 0.655:B:122:A:N7 8:H:518:LYS:HG2 1.99 0.65
Continued on next page...
Page 24 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
7:G:71:UNK:O 7:G:73:UNK:N 2.29 0.651:A:168:GLN:NE2 1:A:172:VAL:O 2.28 0.651:A:331:CYS:O 1:A:492:ARG:NH1 2.30 0.652:D:572:CYS:SG 2:D:577:GLN:O 2.52 0.648:H:464:ILE:N 8:H:464:ILE:HD12 2.12 0.641:A:127:SER:O 1:A:131:LEU:N 2.29 0.641:A:913:LYS:NZ 5:B:58:A:N7 2.41 0.644:E:88:LYS:HG2 4:E:97:GLU:HG2 1.79 0.647:G:49:UNK:O 7:G:75:UNK:O 2.15 0.641:A:139:LEU:O 1:A:143:PHE:HB2 1.97 0.64
2:D:577:GLN:OE1 2:D:579:ILE:CB 2.43 0.645:B:121:G:H2’ 8:H:517:LYS:HD2 1.79 0.64
3:F:100:ASP:OD1 3:F:104:LYS:NZ 2.32 0.632:D:631:ILE:HA 2:D:636:GLU:HB3 1.81 0.631:A:229:ILE:HD11 1:A:472:LEU:HB2 1.80 0.631:A:528:TYR:CB 1:A:530:GLN:NE2 2.62 0.631:A:538:LYS:HE2 1:A:543:ARG:HD3 1.79 0.631:A:1103:LEU:O 1:A:1107:ILE:N 2.30 0.634:E:118:ILE:HG23 4:E:126:ARG:HG2 1.79 0.633:F:104:LYS:O 3:F:108:LEU:HB2 1.98 0.63
1:A:1007:LEU:HD13 1:A:1009:PHE:HB2 1.80 0.631:A:113:THR:HB 1:A:120:GLU:H 1.63 0.634:E:68:ILE:HG12 4:E:133:MET:HG2 1.79 0.631:A:539:LYS:HG3 1:A:541:SER:H 1.62 0.631:A:626:ILE:HD11 1:A:771:ILE:HG12 1.81 0.632:D:553:TYR:HA 2:D:583:VAL:HA 1.80 0.637:G:84:UNK:HA 7:G:99:UNK:HA 1.81 0.625:B:126:U:H3 5:B:144:A:H2 1.45 0.62
7:G:51:UNK:CA 7:G:73:UNK:C 2.66 0.621:A:397:ASN:ND2 1:A:427:ASP:O 2.33 0.621:A:460:ILE:HA 1:A:463:ILE:HD12 1.82 0.621:A:594:SER:O 1:A:598:ALA:HB3 2.00 0.621:A:579:LEU:O 1:A:581:GLN:NE2 2.31 0.62
1:A:605:LYS:HG2 1:A:610:PRO:HA 1.81 0.621:A:412:LYS:NZ 1:A:899:ILE:O 2.32 0.621:A:975:TYR:O 1:A:979:TYR:HB2 2.00 0.621:A:945:GLN:O 1:A:949:HIS:ND1 2.25 0.62
1:A:1070:GLN:NE2 1:A:1074:SER:OG 2.33 0.621:A:224:ILE:O 1:A:416:ASN:ND2 2.33 0.61
1:A:314:ILE:HG23 1:A:387:CYS:HB3 1.82 0.611:A:589:ASP:OD1 1:A:590:ASN:ND2 2.33 0.61
Continued on next page...
Page 25 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
5:B:107:G:H3’ 5:B:108:A:H8 1.65 0.611:A:702:GLN:NE2 1:A:703:ILE:O 2.30 0.611:A:1103:LEU:HA 1:A:1106:LYS:HB2 1.81 0.611:A:63:THR:HG23 1:A:159:THR:HG22 1.83 0.611:A:626:ILE:HG13 1:A:770:GLY:HA2 1.80 0.602:D:560:LYS:N 6:C:2:DT:OP1 2.33 0.60
1:A:1080:LEU:HA 1:A:1084:GLU:HB3 1.81 0.607:G:139:UNK:O 7:G:143:UNK:N 2.35 0.607:G:51:UNK:HA 7:G:74:UNK:N 2.15 0.602:D:652:ILE:HB 2:D:676:GLU:HB2 1.83 0.602:D:573:GLU:O 2:D:576:GLN:NE2 2.34 0.60
2:D:642:LEU:HD12 2:D:645:LYS:HD2 1.84 0.602:D:689:LYS:O 2:D:693:HIS:ND1 2.31 0.60
1:A:881:ILE:HG12 1:A:888:ILE:HG23 1.82 0.601:A:626:ILE:HB 1:A:770:GLY:H 1.64 0.603:F:78:LEU:HB2 3:F:82:ILE:HB 1.83 0.601:A:949:HIS:O 1:A:953:THR:OG1 2.20 0.595:B:120:C:N3 8:H:522:ARG:CB 2.65 0.597:G:51:UNK:C 7:G:74:UNK:CB 2.79 0.59
1:A:125:ASN:OD1 1:A:127:SER:OG 2.17 0.591:A:241:VAL:HG21 1:A:471:VAL:HG22 1.84 0.595:B:110:A:OP2 5:B:155:A:N6 2.35 0.59
1:A:539:LYS:HE3 1:A:541:SER:HB3 1.83 0.591:A:750:LYS:HG2 1:A:754:GLN:HE22 1.66 0.591:A:615:VAL:HG21 1:A:831:ILE:HD11 1.85 0.59
1:A:888:ILE:O 1:A:945:GLN:NE2 2.34 0.593:F:110:GLN:O 3:F:115:SER:OG 2.20 0.595:B:95:G:OP2 5:B:95:G:N2 2.35 0.595:B:140:A:H4’ 8:H:396:VAL:CG1 2.33 0.595:B:60:U:O2’ 5:B:61:G:N2 2.35 0.59
1:A:1008:GLN:HB3 1:A:1012:GLU:HB2 1.85 0.591:A:1098:GLN:NE2 1:A:1102:THR:OG1 2.35 0.59
1:A:463:ILE:O 1:A:467:ILE:HB 2.02 0.591:A:648:ASN:ND2 1:A:705:TYR:OH 2.36 0.591:A:157:VAL:HB 1:A:170:ALA:HB3 1.84 0.591:A:237:ARG:NE 5:B:36:U:O4 2.36 0.591:A:471:VAL:O 1:A:475:ASN:ND2 2.36 0.591:A:533:LEU:HA 1:A:546:MET:HG3 1.83 0.591:A:975:TYR:O 1:A:979:TYR:CB 2.51 0.59
1:A:161:VAL:HG22 1:A:167:LEU:HD11 1.85 0.591:A:239:PRO:HB2 1:A:323:PHE:HD2 1.68 0.59
Continued on next page...
Page 26 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:738:ARG:HD2 7:G:3:UNK:HA 1.84 0.595:B:32:G:H2’ 5:B:33:A:C8 2.37 0.595:B:122:A:N3 8:H:407:TYR:CD2 2.71 0.585:B:146:G:H4’ 5:B:147:G:H4’ 1.86 0.58
3:F:74:ARG:NH2 4:E:129:TYR:OH 2.35 0.581:A:528:TYR:HB2 1:A:530:GLN:HE22 1.68 0.581:A:594:SER:HA 1:A:597:PHE:HD2 1.69 0.584:E:36:CYS:O 4:E:40:ASN:ND2 2.36 0.58
1:A:555:LYS:HA 1:A:558:LYS:HE2 1.84 0.581:A:812:ARG:HE 1:A:817:TYR:HB2 1.69 0.585:B:140:A:H4’ 8:H:396:VAL:HG11 1.85 0.585:B:47:C:H2’ 5:B:48:C:C6 2.39 0.585:B:117:U:O4’ 8:H:526:PHE:CD2 2.55 0.58
1:A:357:GLN:HE21 1:A:361:ASN:HD21 1.51 0.581:A:655:ARG:NH2 5:B:51:A:O3’ 2.36 0.584:E:67:ALA:HB3 4:E:134:LEU:HB2 1.86 0.587:G:78:UNK:N 7:G:105:UNK:O 2.36 0.58
1:A:583:ILE:HG13 1:A:790:GLU:HB3 1.85 0.581:A:984:THR:O 1:A:988:PHE:CB 2.51 0.583:F:14:LEU:HD11 3:F:47:PRO:HG2 1.86 0.587:G:89:UNK:O 7:G:94:UNK:N 2.36 0.582:D:572:CYS:SG 2:D:579:ILE:CB 2.90 0.584:E:114:GLN:OE1 4:E:147:PHE:N 2.37 0.574:E:43:VAL:HG12 4:E:47:LYS:HE3 1.85 0.575:B:117:U:C1’ 8:H:526:PHE:HD2 2.17 0.575:B:149:U:H2’ 5:B:150:G:C8 2.39 0.571:A:882:ASP:O 1:A:887:GLU:N 2.36 0.57
2:D:564:LYS:HD3 6:C:5:DG:H2” 1.85 0.571:A:981:LYS:HE3 1:A:983:ASN:HB2 1.86 0.571:A:971:LYS:NZ 5:B:137:U:OP2 2.33 0.572:D:563:LEU:N 2:D:571:PHE:O 2.38 0.571:A:110:ILE:O 1:A:734:GLN:NE2 2.37 0.57
1:A:796:PHE:HB2 1:A:797:LEU:HD22 1.86 0.571:A:849:LYS:H 1:A:869:SER:HB3 1.69 0.575:B:102:U:H2’ 5:B:103:G:H8 1.69 0.57
7:G:75:UNK:CB 7:G:110:UNK:CA 2.83 0.571:A:1030:TRP:HA 1:A:1033:ILE:HD12 1.86 0.571:A:156:LEU:HD11 1:A:172:VAL:HG12 1.87 0.571:A:390:ASN:O 1:A:394:GLY:N 2.38 0.566:C:9:DT:H2” 6:C:10:DG:H3’ 1.86 0.564:E:73:PHE:HA 4:E:89:LEU:HG 1.87 0.56
Continued on next page...
Page 27 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:34:SER:OG 1:A:35:ASN:N 2.37 0.561:A:333:LEU:HD12 5:B:15:C:H2’ 1.86 0.563:F:18:MET:SD 3:F:22:ARG:NH2 2.79 0.561:A:787:GLY:O 1:A:791:GLU:CB 2.53 0.561:A:880:SER:O 1:A:889:LYS:N 2.33 0.563:F:78:LEU:N 3:F:82:ILE:O 2.36 0.561:A:394:GLY:O 1:A:398:PHE:N 2.35 0.565:B:117:U:C1’ 8:H:526:PHE:CB 2.83 0.56
1:A:794:THR:HG22 1:A:798:LYS:HE2 1.88 0.562:D:687:LEU:HD21 3:F:104:LYS:HD2 1.88 0.561:A:347:ILE:HA 1:A:351:GLU:HB3 1.86 0.56
1:A:110:ILE:HG22 1:A:734:GLN:HG3 1.87 0.561:A:881:ILE:HG23 1:A:888:ILE:HG12 1.88 0.555:B:111:A:H2’ 5:B:112:A:C8 2.41 0.555:B:52:A:O2’ 5:B:53:A:O4’ 2.24 0.55
2:D:661:GLU:HG2 2:D:663:ASN:H 1.71 0.557:G:53:UNK:CB 7:G:62:UNK:CB 2.84 0.551:A:576:LYS:HZ3 1:A:586:SER:HB3 1.71 0.552:D:537:VAL:HG23 2:D:653:PHE:HB2 1.87 0.551:A:156:LEU:HG 1:A:171:GLY:HA3 1.89 0.555:B:124:A:O2’ 5:B:148:A:O2’ 2.16 0.555:B:52:A:N6 6:C:13:DG:OP1 2.34 0.55
4:E:136:MET:HG3 4:E:142:ILE:CD1 2.35 0.553:F:57:ASP:OD1 3:F:60:ARG:NH2 2.39 0.551:A:303:GLU:HA 1:A:306:LEU:HD12 1.87 0.552:D:562:VAL:HA 2:D:572:CYS:HA 1.88 0.554:E:39:ILE:CG1 4:E:136:MET:HE1 2.36 0.551:A:129:GLN:NE2 7:G:107:UNK:O 2.40 0.555:B:140:A:O2’ 8:H:393:ALA:CA 2.54 0.55
1:A:944:ARG:NH2 1:A:1108:SER:O 2.39 0.555:B:121:G:C2’ 8:H:517:LYS:HB3 2.37 0.553:F:40:SER:O 3:F:60:ARG:NH2 2.35 0.551:A:233:ASN:H 1:A:234:HIS:CD2 2.25 0.541:A:786:PHE:O 1:A:790:GLU:HB2 2.07 0.545:B:102:U:H2’ 5:B:103:G:C8 2.42 0.54
1:A:1000:VAL:HA 1:A:1003:ILE:HG22 1.89 0.541:A:234:HIS:CD2 5:B:39:C:H2’ 2.42 0.541:A:229:ILE:HG23 1:A:478:ILE:HG21 1.88 0.547:G:99:UNK:O 7:G:121:UNK:O 2.24 0.54
1:A:626:ILE:HG13 1:A:770:GLY:C 2.27 0.545:B:47:C:H2’ 5:B:48:C:H6 1.70 0.54
Continued on next page...
Page 28 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:849:LYS:HB3 1:A:850:ILE:HG23 1.90 0.543:F:40:SER:HB3 3:F:60:ARG:HE 1.72 0.545:B:115:A:N1 5:B:152:C:N4 2.56 0.54
2:D:553:TYR:OH 2:D:564:LYS:NZ 2.37 0.544:E:39:ILE:HG12 4:E:136:MET:HE1 1.90 0.541:A:694:TYR:HB2 1:A:696:PHE:HE1 1.73 0.544:E:39:ILE:HD11 4:E:136:MET:HE1 1.89 0.541:A:501:LYS:HA 1:A:504:ILE:HD12 1.89 0.541:A:961:MET:O 1:A:965:PHE:CB 2.55 0.54
1:A:533:LEU:HD23 1:A:760:PHE:HB2 1.90 0.541:A:96:SER:HA 1:A:99:LEU:HD12 1.90 0.544:E:135:LYS:HZ1 4:E:137:ARG:HD3 1.72 0.542:D:606:GLN:NE2 2:D:673:LEU:O 2.42 0.531:A:106:TYR:HB2 1:A:109:GLN:HG3 1.91 0.531:A:530:GLN:CB 1:A:757:VAL:HG13 2.37 0.531:A:723:GLN:NE2 1:A:724:SER:O 2.41 0.531:A:826:ASN:O 1:A:830:LEU:HB2 2.08 0.531:A:78:LYS:HZ3 4:E:104:LYS:HE3 1.74 0.531:A:360:GLU:O 1:A:364:ASN:ND2 2.42 0.531:A:649:LYS:HB3 1:A:731:VAL:HG12 1.91 0.532:D:543:SER:O 2:D:545:GLN:NE2 2.42 0.53
1:A:588:PHE:HE2 1:A:591:LYS:H 1.55 0.531:A:981:LYS:HG2 1:A:983:ASN:H 1.74 0.534:E:130:VAL:HG12 4:E:149:ILE:HA 1.90 0.532:D:660:LYS:NZ 6:C:4:DG:O6 2.42 0.532:D:524:ALA:HB1 2:D:668:ILE:HG21 1.89 0.534:E:100:ILE:HA 4:E:143:GLN:HE22 1.73 0.53
1:A:626:ILE:HG13 1:A:770:GLY:CA 2.36 0.535:B:112:A:H2’ 5:B:113:A:C8 2.43 0.53
1:A:384:ILE:HG21 1:A:401:PHE:HE2 1.72 0.532:D:656:GLN:HB2 2:D:673:LEU:HD11 1.90 0.531:A:626:ILE:HB 1:A:770:GLY:HA2 1.90 0.531:A:340:LEU:HA 1:A:343:GLN:HE21 1.73 0.521:A:626:ILE:CB 1:A:770:GLY:CA 2.86 0.521:A:336:ASN:N 1:A:336:ASN:OD1 2.43 0.521:A:536:ILE:HB 1:A:544:PRO:HA 1.89 0.521:A:827:ALA:HA 1:A:830:LEU:HD13 1.91 0.522:D:535:PHE:N 2:D:655:ILE:O 2.42 0.521:A:604:TRP:O 1:A:608:GLY:N 2.43 0.52
2:D:514:TYR:HE1 2:D:685:LYS:HB3 1.74 0.524:E:58:TYR:CE1 4:E:138:LYS:HD3 2.44 0.52
Continued on next page...
Page 29 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:305:ASP:HA 1:A:308:LEU:HD12 1.92 0.521:A:626:ILE:HG13 1:A:771:ILE:N 2.24 0.525:B:121:G:O5’ 8:H:518:LYS:HA 2.09 0.522:D:586:MET:O 2:D:588:ARG:NH1 2.41 0.521:A:454:LYS:NZ 1:A:458:ASP:OD2 2.41 0.521:A:125:ASN:HB2 1:A:734:GLN:NE2 2.25 0.521:A:623:TYR:O 1:A:626:ILE:HG12 2.10 0.52
1:A:30:LEU:HD13 1:A:66:ALA:HB1 1.91 0.521:A:28:SER:HB3 1:A:693:PRO:HD2 1.91 0.521:A:790:GLU:O 1:A:794:THR:OG1 2.20 0.521:A:907:ILE:O 1:A:915:GLN:NE2 2.39 0.522:D:515:SER:N 2:D:536:TYR:O 2.40 0.522:D:572:CYS:N 2:D:577:GLN:O 2.33 0.527:G:97:UNK:C 7:G:123:UNK:CB 2.88 0.521:A:166:TYR:O 1:A:730:ILE:N 2.38 0.521:A:815:ASP:N 1:A:815:ASP:OD1 2.43 0.521:A:860:ASP:HA 1:A:863:LEU:HD12 1.90 0.523:F:27:THR:HA 3:F:74:ARG:HG2 1.91 0.525:B:140:A:H4’ 8:H:396:VAL:HB 1.92 0.52
1:A:528:TYR:CB 1:A:530:GLN:HE22 2.23 0.511:A:85:SER:OG 1:A:86:GLN:OE1 2.22 0.513:F:112:ASP:OD2 3:F:113:LYS:NZ 2.41 0.513:F:15:PHE:HA 3:F:21:PHE:HZ 1.75 0.517:G:53:UNK:O 7:G:61:UNK:N 2.43 0.51
1:A:479:THR:OG1 1:A:480:GLU:N 2.44 0.514:E:141:GLN:O 4:E:142:ILE:HD13 2.10 0.51
1:A:1034:VAL:HG22 1:A:1054:ILE:HD13 1.91 0.511:A:317:ASN:ND2 1:A:387:CYS:O 2.43 0.511:A:440:GLN:HA 1:A:443:THR:HB 1.91 0.511:A:741:THR:OG1 1:A:742:LYS:N 2.43 0.511:A:593:ILE:HD13 1:A:811:MET:HG3 1.93 0.514:E:107:ASP:HA 4:E:110:PRO:HD2 1.92 0.514:E:46:ALA:HB1 4:E:138:LYS:CE 2.22 0.511:A:599:GLN:NE2 1:A:934:PRO:O 2.42 0.514:E:125:ASN:O 4:E:128:LYS:NZ 2.44 0.514:E:58:TYR:CE2 4:E:136:MET:CG 2.84 0.514:E:91:ASP:OD1 4:E:94:GLY:N 2.44 0.513:F:55:VAL:HB 3:F:82:ILE:HA 1.91 0.514:E:58:TYR:HE2 4:E:136:MET:CG 2.05 0.511:A:81:GLN:HE22 4:E:82:SER:H 1.57 0.51
1:A:64:ILE:N 1:A:158:PHE:O 2.31 0.51Continued on next page...
Page 30 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:642:GLN:HA 1:A:740:ILE:HG23 1.93 0.511:A:916:LEU:HG 1:A:992:ILE:HG12 1.93 0.511:A:916:LEU:HA 1:A:919:LYS:HB2 1.92 0.505:B:122:A:C2 8:H:407:TYR:CD2 2.98 0.50
1:A:534:ARG:HH11 1:A:545:ILE:HD11 1.76 0.501:A:882:ASP:OD1 1:A:884:ASN:ND2 2.44 0.506:C:17:DG:H2’ 6:C:18:DG:C8 2.46 0.503:F:112:ASP:O 3:F:116:SER:N 2.43 0.501:A:632:LEU:O 1:A:636:ASN:ND2 2.44 0.505:B:141:U:C5’ 8:H:392:LYS:HD3 2.41 0.50
1:A:507:LEU:HD21 1:A:765:PHE:HB2 1.93 0.501:A:1038:LYS:NZ 5:B:71:C:OP2 2.31 0.501:A:481:LYS:NZ 1:A:539:LYS:O 2.35 0.501:A:746:HIS:HA 1:A:749:LEU:HD12 1.93 0.501:A:905:VAL:HA 1:A:960:PHE:HE1 1.76 0.501:A:337:TYR:OH 5:B:16:A:O3’ 2.27 0.502:D:552:TYR:N 2:D:584:HIS:O 2.40 0.501:A:626:ILE:CD1 1:A:771:ILE:CG1 2.86 0.501:A:934:PRO:HB2 1:A:937:ASN:H 1.75 0.501:A:436:ASP:OD1 1:A:448:TYR:OH 2.29 0.501:A:594:SER:O 1:A:598:ALA:CB 2.60 0.50
1:A:924:PHE:CE1 5:B:51:A:H2’ 2.46 0.502:D:517:ILE:HD11 2:D:591:VAL:HG12 1.94 0.501:A:1017:ILE:O 1:A:1021:PHE:CB 2.55 0.501:A:624:ASP:HA 1:A:770:GLY:HA3 1.94 0.508:H:474:LEU:O 8:H:477:GLN:HG2 2.11 0.50
1:A:947:TYR:HB2 1:A:1032:ILE:HD11 1.94 0.491:A:608:GLY:O 1:A:609:ARG:NH1 2.38 0.492:D:533:LYS:HB3 2:D:657:PHE:CE1 2.47 0.491:A:749:LEU:HD23 1:A:752:ILE:HD11 1.93 0.491:A:123:ASN:HA 1:A:736:LYS:HE3 1.93 0.491:A:953:THR:O 1:A:957:PHE:HB2 2.13 0.491:A:53:ASP:O 1:A:57:GLN:N 2.46 0.491:A:614:TYR:O 1:A:851:THR:OG1 2.30 0.495:B:139:U:O2’ 8:H:400:ARG:NH1 2.46 0.491:A:235:MET:O 5:B:18:U:N3 2.46 0.491:A:412:LYS:N 1:A:415:GLU:OE1 2.45 0.495:B:120:C:C4 8:H:522:ARG:CA 2.94 0.49
1:A:658:ARG:NH2 1:A:697:ASN:HB2 2.20 0.492:D:518:GLU:HB2 2:D:595:THR:HB 1.94 0.492:D:564:LYS:NZ 6:C:6:DG:N3 2.61 0.49
Continued on next page...
Page 31 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:1039:LYS:O 1:A:1041:LYS:NZ 2.44 0.481:A:27:ILE:HG21 1:A:695:TYR:HA 1.94 0.481:A:937:ASN:HB2 1:A:942:LEU:HD21 1.93 0.481:A:891:ILE:O 1:A:948:HIS:NE2 2.45 0.485:B:121:G:O4’ 8:H:520:GLU:HB3 2.11 0.481:A:14:LEU:HA 1:A:1002:LYS:HD2 1.96 0.481:A:452:LYS:HA 1:A:455:ILE:HD12 1.94 0.482:D:602:ILE:HG13 2:D:672:VAL:HG21 1.95 0.48
5:B:120:C:C5 8:H:522:ARG:HA 2.49 0.481:A:882:ASP:N 1:A:887:GLU:O 2.45 0.48
1:A:926:ASN:OD1 1:A:926:ASN:N 2.44 0.485:B:2:U:H4’ 5:B:3:A:H8 1.78 0.48
2:D:529:ILE:HG21 2:D:663:ASN:HD21 1.78 0.481:A:1053:LYS:NZ 5:B:61:G:N7 2.62 0.481:A:585:TYR:CD1 1:A:593:ILE:HG13 2.49 0.481:A:563:GLN:HG3 1:A:645:TYR:OH 2.13 0.481:A:701:ARG:CZ 1:A:703:ILE:HG12 2.44 0.481:A:619:ILE:HA 1:A:845:PHE:HB3 1.96 0.485:B:153:U:H2’ 5:B:154:U:C2 2.49 0.48
1:A:390:ASN:HB2 1:A:395:LYS:HA 1.95 0.481:A:400:VAL:O 1:A:404:LYS:HG2 2.13 0.48
1:A:446:ARG:HH21 5:B:134:C:H1’ 1.78 0.485:B:113:A:H2’ 5:B:114:G:C8 2.47 0.485:B:121:G:H2’ 8:H:517:LYS:CB 2.43 0.484:E:44:LYS:HA 4:E:47:LYS:HD2 1.96 0.485:B:61:G:O2’ 5:B:63:U:OP1 2.23 0.48
7:G:48:UNK:HA 7:G:77:UNK:O 2.13 0.484:E:65:GLU:OE2 4:E:137:ARG:HA 2.14 0.488:H:487:LEU:CB 8:H:498:VAL:HG22 2.43 0.481:A:492:ARG:HB2 1:A:495:ILE:HD12 1.94 0.481:A:652:LEU:HD11 1:A:727:ARG:HG3 1.96 0.481:A:742:LYS:HA 1:A:745:ILE:HD12 1.96 0.481:A:944:ARG:HA 1:A:947:TYR:CE1 2.49 0.485:B:117:U:C1’ 8:H:526:PHE:CD2 2.96 0.48
1:A:738:ARG:NH1 7:G:2:UNK:O 2.47 0.481:A:108:GLN:OE1 1:A:108:GLN:N 2.42 0.481:A:124:ILE:HG13 1:A:736:LYS:HG2 1.95 0.481:A:897:GLN:HA 1:A:900:ASN:HD22 1.78 0.486:C:9:DT:H1’ 6:C:10:DG:H8 1.78 0.48
2:D:560:LYS:HB3 2:D:573:GLU:HB2 1.96 0.481:A:1019:GLU:O 1:A:1023:ASN:ND2 2.47 0.47
Continued on next page...
Page 32 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:1044:LYS:HA 1:A:1047:LEU:HB2 1.96 0.471:A:32:TYR:HB3 1:A:67:SER:HB3 1.96 0.471:A:532:LYS:HA 1:A:759:SER:H 1.79 0.475:B:122:A:N6 8:H:514:ILE:CB 2.77 0.475:B:146:G:N2 5:B:148:A:N7 2.60 0.47
2:D:608:SER:HA 2:D:611:ILE:HD12 1.95 0.471:A:694:TYR:HB2 1:A:696:PHE:CE1 2.49 0.478:H:515:LYS:HB3 8:H:515:LYS:NZ 2.29 0.471:A:298:PHE:HD2 1:A:304:ARG:HB2 1.80 0.471:A:529:PRO:C 1:A:554:GLN:NE2 2.68 0.47
1:A:614:TYR:HB2 1:A:818:LEU:HD11 1.96 0.471:A:529:PRO:C 1:A:554:GLN:HE21 2.17 0.471:A:910:LYS:HD2 5:B:135:U:H1’ 1.95 0.475:B:140:A:H4’ 8:H:396:VAL:CB 2.44 0.476:C:14:DT:H1’ 6:C:15:DT:C6 2.49 0.474:E:39:ILE:CD1 4:E:136:MET:HE1 2.45 0.472:D:651:PHE:HB2 2:D:653:PHE:CZ 2.50 0.472:D:606:GLN:HE22 2:D:674:LYS:HD2 1.79 0.474:E:70:THR:HG23 4:E:150:VAL:HG21 1.96 0.473:F:10:TYR:CG 3:F:74:ARG:HD3 2.48 0.477:G:51:UNK:HA 7:G:73:UNK:O 1.94 0.471:A:761:ASN:OD1 1:A:762:LYS:N 2.48 0.471:A:500:SER:O 1:A:503:THR:OG1 2.24 0.47
1:A:565:LEU:HD13 1:A:777:ILE:HB 1.96 0.471:A:961:MET:O 1:A:965:PHE:HB3 2.15 0.475:B:19:C:HO2’ 5:B:20:A:H8 1.63 0.472:D:554:ARG:N 2:D:582:GLN:O 2.33 0.47
1:A:123:ASN:HB2 1:A:734:GLN:HB3 1.96 0.471:A:124:ILE:H 1:A:734:GLN:HB3 1.79 0.471:A:314:ILE:HA 1:A:317:ASN:HD22 1.79 0.471:A:603:LYS:O 1:A:607:LYS:N 2.37 0.47
2:D:584:HIS:ND1 2:D:604:ASP:OD2 2.43 0.474:E:69:ILE:HA 4:E:159:HIS:CE1 2.50 0.473:F:19:ALA:O 3:F:24:LYS:NZ 2.39 0.47
1:A:1027:TRP:CD1 1:A:1058:ARG:HG2 2.49 0.471:A:418:LYS:N 1:A:421:ASP:OD2 2.41 0.47
1:A:612:LEU:HD23 1:A:822:ASP:HB3 1.97 0.471:A:997:VAL:HA 1:A:1000:VAL:HG12 1.96 0.461:A:1098:GLN:O 1:A:1102:THR:CB 2.63 0.46
1:A:1097:ILE:HD12 1:A:1100:ILE:HB 1.98 0.461:A:565:LEU:HD22 1:A:777:ILE:HA 1.96 0.46
Continued on next page...
Page 33 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:954:VAL:O 1:A:957:PHE:N 2.45 0.461:A:958:TYR:HE1 1:A:1040:LYS:HG2 1.80 0.461:A:107:VAL:HG21 1:A:168:GLN:HG2 1.96 0.461:A:624:ASP:HB3 1:A:767:GLN:HE22 1.80 0.461:A:849:LYS:HB3 1:A:850:ILE:H 1.44 0.461:A:795:GLN:O 1:A:799:ASN:ND2 2.49 0.461:A:341:LYS:NZ 5:B:17:U:OP1 2.48 0.461:A:28:SER:OG 1:A:693:PRO:O 2.23 0.461:A:614:TYR:CG 1:A:874:CYS:HB2 2.51 0.463:F:35:GLU:O 3:F:37:GLN:NE2 2.48 0.465:B:71:C:H4’ 5:B:89:A:H61 1.80 0.46
1:A:404:LYS:HB3 1:A:422:TYR:CZ 2.51 0.465:B:46:C:HO2’ 5:B:47:C:C5’ 2.28 0.46
1:A:657:LYS:HD2 1:A:1002:LYS:HD2 1.97 0.462:D:646:LEU:HD23 2:D:646:LEU:HA 1.78 0.461:A:100:LEU:HD22 1:A:103:LYS:HD2 1.98 0.461:A:395:LYS:N 1:A:430:ASP:OD2 2.49 0.465:B:43:C:O4’ 6:C:7:DG:N2 2.37 0.46
2:D:591:VAL:HG23 2:D:600:VAL:HG21 1.97 0.461:A:380:LEU:HD21 1:A:405:LEU:HD22 1.98 0.451:A:53:ASP:OD2 1:A:56:PHE:N 2.37 0.452:D:598:ILE:HG22 2:D:600:VAL:HG13 1.97 0.454:E:136:MET:HA 4:E:142:ILE:HD12 1.97 0.451:A:241:VAL:HG22 1:A:475:ASN:HD21 1.82 0.451:A:594:SER:HA 1:A:597:PHE:CD2 2.50 0.451:A:232:CYS:HB3 1:A:493:LYS:HZ1 1.80 0.451:A:658:ARG:HH12 1:A:697:ASN:HD22 1.63 0.451:A:767:GLN:NE2 1:A:769:ARG:O 2.49 0.45
6:C:7:DG:H1’ 6:C:8:DT:C4 2.51 0.454:E:121:GLN:HE22 4:E:128:LYS:HG3 1.81 0.451:A:435:VAL:O 1:A:452:LYS:NZ 2.39 0.45
2:D:585:LEU:HD22 2:D:587:LEU:HD21 1.99 0.458:H:484:ASN:OD1 8:H:486:LYS:HG2 2.15 0.451:A:790:GLU:O 1:A:794:THR:CB 2.63 0.455:B:141:U:C4’ 8:H:392:LYS:HD3 2.45 0.45
1:A:1097:ILE:HD11 1:A:1101:LYS:HE3 1.98 0.451:A:849:LYS:HD3 1:A:849:LYS:HA 1.81 0.451:A:139:LEU:HA 1:A:139:LEU:HD23 1.84 0.451:A:19:ASP:O 1:A:22:THR:OG1 2.26 0.451:A:738:ARG:H 1:A:738:ARG:HD3 1.82 0.455:B:145:U:H5’ 5:B:146:G:H2’ 1.99 0.45
Continued on next page...
Page 34 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:536:ILE:HD13 1:A:536:ILE:HA 1.77 0.451:A:551:LYS:HB2 1:A:554:GLN:HB2 1.97 0.451:A:658:ARG:HH12 1:A:697:ASN:ND2 2.15 0.452:D:566:HIS:HB3 5:B:42:U:C4 2.51 0.453:F:58:ASN:O 3:F:60:ARG:NH2 2.49 0.45
1:A:160:LYS:HD2 1:A:166:TYR:HE1 1.82 0.451:A:230:PHE:O 1:A:473:ARG:NH1 2.48 0.45
1:A:769:ARG:NH2 1:A:842:GLY:O 2.50 0.451:A:620:LYS:HG2 1:A:845:PHE:HA 1.98 0.451:A:911:ASN:OD1 1:A:911:ASN:N 2.50 0.451:A:961:MET:O 1:A:965:PHE:HB2 2.17 0.452:D:564:LYS:HZ1 6:C:6:DG:H21 1.65 0.451:A:239:PRO:HA 1:A:474:TYR:HE2 1.82 0.45
1:A:1004:LEU:HD21 1:A:1022:LYS:HB3 1.99 0.441:A:131:LEU:HA 1:A:136:PHE:CE2 2.52 0.441:A:529:PRO:HA 1:A:554:GLN:CG 2.47 0.441:A:583:ILE:HA 1:A:794:THR:HG21 1.98 0.441:A:927:GLN:OE1 1:A:953:THR:OG1 2.32 0.441:A:389:PRO:HB2 1:A:392:LEU:H 1.83 0.441:A:825:GLN:O 1:A:829:ASN:ND2 2.50 0.441:A:849:LYS:HB2 1:A:869:SER:H 1.82 0.444:E:146:TYR:HE2 4:E:148:SER:HB2 1.82 0.441:A:641:ILE:HG22 1:A:642:GLN:H 1.82 0.441:A:912:LEU:HB3 1:A:975:TYR:CE2 2.52 0.441:A:979:TYR:CE1 1:A:987:ASN:HB2 2.52 0.441:A:760:PHE:H 1:A:763:VAL:HG12 1.82 0.441:A:76:LYS:H 1:A:76:LYS:HG2 1.65 0.441:A:958:TYR:O 1:A:962:THR:OG1 2.22 0.44
2:D:588:ARG:NH2 6:C:3:DT:O2 2.51 0.444:E:170:ARG:HE 4:E:174:ILE:HD11 1.83 0.443:F:12:ARG:HG2 3:F:27:THR:HB 2.00 0.445:B:96:U:H2’ 5:B:97:G:C8 2.53 0.44
4:E:114:GLN:HB3 4:E:147:PHE:HB3 1.98 0.447:G:137:UNK:O 7:G:139:UNK:N 2.50 0.441:A:12:GLN:O 1:A:1002:LYS:NZ 2.36 0.44
1:A:337:TYR:CZ 1:A:341:LYS:HD2 2.53 0.441:A:628:GLN:NE2 1:A:768:LYS:O 2.49 0.444:E:63:ALA:H 4:E:170:ARG:NH2 2.16 0.44
1:A:797:LEU:HD11 1:A:833:GLN:NE2 2.32 0.445:B:46:C:O2’ 5:B:47:C:H6 2.01 0.44
1:A:1046:TYR:HD1 1:A:1049:LYS:HG3 1.82 0.44Continued on next page...
Page 35 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:552:ASP:N 1:A:552:ASP:OD1 2.48 0.441:A:569:GLN:HE21 1:A:573:ARG:NH2 2.16 0.441:A:809:LEU:HA 1:A:810:LEU:HD12 2.00 0.442:D:568:ASP:HB3 2:D:571:PHE:HB2 1.99 0.442:D:682:GLU:HA 2:D:685:LYS:HG2 2.00 0.444:E:77:GLN:HB3 4:E:86:MET:HB3 2.00 0.444:E:79:ILE:HD11 4:E:86:MET:HB2 1.99 0.441:A:115:ILE:HG12 2:D:590:PHE:CE2 2.53 0.431:A:137:ARG:O 1:A:141:ASN:ND2 2.51 0.43
1:A:340:LEU:HD23 1:A:343:GLN:HE21 1.81 0.431:A:932:PHE:HZ 1:A:946:LEU:HB2 1.83 0.435:B:31:A:H5” 5:B:32:G:H8 1.83 0.43
4:E:102:LYS:HB2 4:E:107:ASP:H 1.83 0.434:E:117:GLU:HB2 4:E:147:PHE:HE2 1.83 0.431:A:20:LEU:HD22 1:A:166:TYR:HD2 1.84 0.431:A:525:PHE:CZ 1:A:751:HIS:HD2 2.37 0.43
1:A:985:ASN:HD22 1:A:989:LEU:HD12 1.82 0.434:E:130:VAL:HG12 4:E:149:ILE:HG13 2.00 0.43
3:F:40:SER:O 3:F:58:ASN:N 2.45 0.431:A:355:ASN:N 1:A:355:ASN:OD1 2.49 0.43
1:A:889:LYS:HD2 1:A:945:GLN:NE2 2.34 0.435:B:71:C:O2’ 5:B:90:A:N6 2.47 0.435:B:140:A:O2’ 8:H:393:ALA:CB 2.66 0.43
1:A:229:ILE:HD12 1:A:229:ILE:HA 1.75 0.431:A:642:GLN:O 1:A:708:TYR:HB3 2.18 0.435:B:125:U:H2’ 5:B:126:U:C6 2.53 0.431:A:567:ASP:N 1:A:567:ASP:OD1 2.49 0.43
1:A:613:TYR:CD2 1:A:824:GLN:HB2 2.53 0.431:A:622:CYS:HB2 1:A:786:PHE:HE2 1.83 0.435:B:124:A:H2’ 5:B:125:U:C6 2.54 0.435:B:44:A:HO2’ 5:B:45:A:H8 1.64 0.43
2:D:654:GLU:HG2 2:D:673:LEU:HD12 2.00 0.431:A:113:THR:O 1:A:119:VAL:HA 2.19 0.43
1:A:809:LEU:HD23 1:A:809:LEU:HA 1.73 0.434:E:60:TRP:HD1 4:E:167:TYR:CE1 2.36 0.431:A:696:PHE:HD2 1:A:699:LYS:HE2 1.84 0.431:A:894:GLN:HE22 1:A:896:GLN:HB3 1.84 0.432:D:593:ASP:OD1 2:D:596:GLY:N 2.34 0.431:A:1001:CYS:O 1:A:1022:LYS:HD2 2.19 0.43
1:A:393:LEU:HD12 1:A:398:PHE:HD1 1.84 0.431:A:440:GLN:OE1 1:A:444:GLN:N 2.51 0.43
Continued on next page...
Page 36 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:797:LEU:HA 1:A:797:LEU:HD13 1.70 0.431:A:909:ILE:HG23 5:B:135:U:C5 2.54 0.431:A:979:TYR:OH 1:A:983:ASN:O 2.28 0.435:B:119:U:H2’ 5:B:120:C:O4’ 2.19 0.435:B:90:A:H2’ 5:B:91:A:C8 2.54 0.435:B:94:A:H3’ 5:B:95:G:N2 2.30 0.43
2:D:572:CYS:SG 2:D:579:ILE:HG21 2.56 0.431:A:1079:GLN:NE2 1:A:1081:ASN:OD1 2.40 0.431:A:481:LYS:HA 1:A:481:LYS:HD3 1.78 0.431:A:637:GLN:NE2 1:A:639:ASP:OD2 2.52 0.431:A:797:LEU:HD12 1:A:830:LEU:HG 2.00 0.431:A:873:GLU:HG3 1:A:882:ASP:HA 2.01 0.432:D:554:ARG:HD3 2:D:559:GLY:HA2 2.00 0.431:A:316:GLN:O 1:A:320:ASN:ND2 2.52 0.421:A:396:LYS:N 1:A:430:ASP:OD2 2.38 0.421:A:392:LEU:HA 1:A:433:TRP:HE1 1.83 0.421:A:912:LEU:HB3 1:A:975:TYR:HE2 1.83 0.42
5:B:22:A:H2’ 5:B:23:U:C6 2.53 0.425:B:37:G:H2’ 5:B:38:U:C6 2.54 0.42
1:A:993:LEU:HD11 1:A:1033:ILE:HD13 2.00 0.423:F:33:CYS:HB3 3:F:43:ILE:HG22 2.01 0.421:A:105:ASN:HB3 1:A:173:CYS:SG 2.59 0.421:A:565:LEU:O 1:A:565:LEU:HG 2.18 0.42
1:A:565:LEU:HD21 1:A:780:VAL:HB 2.01 0.421:A:882:ASP:HB3 1:A:887:GLU:HB3 2.01 0.421:A:622:CYS:SG 1:A:623:TYR:N 2.92 0.422:D:534:GLU:OE2 2:D:656:GLN:NE2 2.52 0.424:E:74:GLU:HA 4:E:127:HIS:CD2 2.55 0.42
1:A:1017:ILE:HD12 1:A:1020:ILE:HB 2.02 0.421:A:623:TYR:HD2 1:A:773:GLN:HG2 1.84 0.426:C:16:DG:H2’ 6:C:17:DG:C8 2.55 0.42
2:D:682:GLU:HG2 2:D:682:GLU:H 1.53 0.424:E:134:LEU:HD22 4:E:142:ILE:HG22 2.00 0.423:F:114:LEU:O 3:F:118:PHE:N 2.43 0.423:F:79:ASN:N 3:F:79:ASN:OD1 2.51 0.421:A:103:LYS:O 1:A:104:GLN:NE2 2.53 0.421:A:175:ASN:O 1:A:178:PHE:N 2.47 0.421:A:406:TYR:O 1:A:410:GLN:HB2 2.19 0.42
1:A:593:ILE:HG21 1:A:593:ILE:HD13 1.85 0.421:A:21:LEU:HD21 1:A:64:ILE:HD12 2.02 0.421:A:920:LEU:HA 1:A:920:LEU:HD13 1.70 0.42
Continued on next page...
Page 37 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
5:B:101:A:H2’ 5:B:102:U:H6 1.85 0.424:E:127:HIS:H 4:E:128:LYS:HZ3 1.65 0.421:A:396:LYS:NZ 1:A:430:ASP:OD1 2.36 0.421:A:29:ALA:N 1:A:695:TYR:HE2 2.18 0.42
1:A:939:PHE:HA 1:A:942:LEU:HD12 2.02 0.428:H:487:LEU:HB3 8:H:498:VAL:HG22 2.02 0.425:B:138:U:O2’ 5:B:139:U:O4’ 2.37 0.42
4:E:29:GLN:HE22 4:E:65:GLU:HB3 1.85 0.421:A:1068:SER:HA 1:A:1071:LEU:HD12 2.00 0.421:A:131:LEU:HA 1:A:136:PHE:HE2 1.85 0.421:A:216:GLU:HB3 1:A:219:TYR:HD1 1.84 0.421:A:232:CYS:SG 1:A:233:ASN:N 2.93 0.421:A:548:PHE:HE2 1:A:775:LEU:HA 1.85 0.421:A:912:LEU:N 1:A:975:TYR:OH 2.47 0.42
1:A:328:LYS:HG2 5:B:15:C:N1 2.35 0.425:B:66:U:O2’ 5:B:68:U:OP2 2.37 0.42
4:E:108:GLU:O 4:E:111:GLU:HB3 2.20 0.423:F:21:PHE:HB2 3:F:22:ARG:HG3 2.01 0.421:A:380:LEU:HA 1:A:383:ILE:HD12 2.01 0.421:A:645:TYR:CD2 1:A:737:PRO:HB2 2.55 0.421:A:822:ASP:OD1 1:A:823:SER:N 2.53 0.421:A:979:TYR:CE2 1:A:981:LYS:HB3 2.55 0.422:D:625:GLN:O 2:D:629:ASN:ND2 2.52 0.42
1:A:1003:ILE:HD12 1:A:1003:ILE:HA 1.92 0.411:A:128:ARG:HA 1:A:131:LEU:HB2 2.01 0.411:A:534:ARG:NH1 1:A:545:ILE:HD11 2.35 0.411:A:622:CYS:HB3 1:A:815:ASP:HB3 2.02 0.411:A:424:CYS:HB3 5:B:136:A:C8 2.55 0.411:A:570:LEU:HD23 1:A:570:LEU:HA 1.81 0.411:A:638:SER:HA 1:A:742:LYS:HE3 2.01 0.411:A:727:ARG:HA 1:A:728:PRO:HD2 1.83 0.411:A:909:ILE:N 1:A:911:ASN:OD1 2.53 0.41
1:A:969:LEU:HD22 1:A:971:LYS:HE2 2.02 0.411:A:989:LEU:HA 1:A:992:ILE:HG22 2.02 0.411:A:995:TYR:O 1:A:998:GLU:HB3 2.20 0.415:B:86:U:H1’ 5:B:90:A:N1 2.34 0.41
2:D:514:TYR:CE1 2:D:685:LYS:HB3 2.54 0.414:E:138:LYS:HA 4:E:138:LYS:HD2 1.81 0.41
4:E:168:LEU:HD13 4:E:168:LEU:HA 1.86 0.411:A:95:ASP:O 1:A:99:LEU:N 2.46 0.41
1:A:1063:LYS:NZ 5:B:65:A:H5’ 2.35 0.41Continued on next page...
Page 38 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:165:GLY:N 1:A:728:PRO:HB3 2.34 0.411:A:310:PHE:HD2 1:A:392:LEU:HD13 1.85 0.411:A:528:TYR:O 1:A:530:GLN:OE1 2.39 0.41
1:A:588:PHE:CE2 1:A:593:ILE:HG22 2.56 0.411:A:916:LEU:HD12 1:A:916:LEU:HA 1.92 0.41
5:B:151:U:H2’ 5:B:152:C:C6 2.54 0.418:H:486:LYS:HE2 8:H:497:ASP:OD2 2.19 0.411:A:389:PRO:HD2 1:A:392:LEU:HD23 2.02 0.411:A:59:PHE:CE2 1:A:135:ASN:HB3 2.56 0.411:A:1037:LEU:HB3 1:A:1047:LEU:HD22 2.02 0.411:A:224:ILE:HB 1:A:416:ASN:HD21 1.86 0.41
1:A:326:LEU:HD13 1:A:329:LYS:HD2 2.02 0.411:A:497:LYS:HE2 1:A:497:LYS:HB3 1.88 0.411:A:547:THR:HG22 5:B:46:C:H5’ 2.02 0.411:A:530:GLN:N 1:A:554:GLN:NE2 2.68 0.411:A:582:LYS:HG2 1:A:790:GLU:OE1 2.21 0.415:B:111:A:N1 5:B:154:U:H2’ 2.36 0.41
1:A:226:ARG:HD3 1:A:415:GLU:O 2.21 0.415:B:67:A:O2’ 5:B:68:U:O4’ 2.36 0.41
2:D:544:ILE:HG13 2:D:544:ILE:H 1.69 0.412:D:556:THR:OG1 2:D:584:HIS:NE2 2.52 0.414:E:84:LYS:HA 4:E:84:LYS:HD3 1.80 0.41
1:A:125:ASN:HB2 1:A:734:GLN:HE21 1.86 0.411:A:59:PHE:HE2 1:A:139:LEU:HD11 1.86 0.411:A:492:ARG:HA 1:A:492:ARG:HD2 1.92 0.416:C:15:DT:H2’ 6:C:16:DG:C8 2.56 0.414:E:166:ARG:O 4:E:170:ARG:HB2 2.21 0.413:F:105:LEU:O 3:F:109:SER:OG 2.28 0.418:H:464:ILE:N 8:H:464:ILE:CD1 2.81 0.41
1:A:1002:LYS:HD3 1:A:1002:LYS:HA 1.88 0.415:B:93:A:H2’ 5:B:94:A:H8 1.86 0.41
3:F:20:GLN:HA 3:F:24:LYS:HD2 2.03 0.411:A:1010:GLU:HB3 1:A:1086:GLU:HG3 2.01 0.411:A:20:LEU:HD22 1:A:166:TYR:CD2 2.56 0.411:A:330:PHE:HD2 1:A:379:PHE:HD1 1.67 0.411:A:364:ASN:OD1 1:A:540:GLY:HA3 2.21 0.41
5:B:6:C:H2’ 5:B:7:G:H8 1.86 0.412:D:563:LEU:HB2 2:D:573:GLU:HG2 2.02 0.414:E:61:TYR:CD2 4:E:171:LYS:HB2 2.56 0.411:A:1098:GLN:O 1:A:1102:THR:OG1 2.32 0.411:A:106:TYR:H 1:A:109:GLN:CD 2.24 0.41
Continued on next page...
Page 39 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...
Atom-1 Atom-2 Interatomicdistance (Å)
Clashoverlap (Å)
1:A:133:SER:OG 1:A:136:PHE:N 2.45 0.411:A:106:TYR:CD1 1:A:172:VAL:HA 2.56 0.412:D:566:HIS:HB2 5:B:41:U:C5 2.56 0.414:E:84:LYS:HG3 4:E:102:LYS:HG2 2.02 0.411:A:572:PHE:O 1:A:576:LYS:HB3 2.22 0.401:A:921:ARG:C 1:A:923:LEU:H 2.24 0.40
1:A:446:ARG:HG3 5:B:137:U:C4 2.56 0.404:E:100:ILE:HG22 4:E:144:LEU:HB3 2.03 0.403:F:69:LYS:HB2 3:F:69:LYS:HE2 1.90 0.407:G:71:UNK:C 7:G:73:UNK:N 2.84 0.405:B:140:A:C4’ 8:H:396:VAL:CG1 2.93 0.40
8:H:487:LEU:HB2 8:H:498:VAL:HG22 2.02 0.401:A:1093:LEU:C 1:A:1098:GLN:HE21 2.24 0.401:A:361:ASN:HA 1:A:364:ASN:HD22 1.86 0.401:A:419:VAL:HG12 1:A:423:ILE:HD11 2.04 0.401:A:987:ASN:HA 1:A:990:LYS:HB3 2.03 0.40
2:D:627:VAL:HG13 2:D:639:ILE:HG21 2.04 0.403:F:51:ASN:HA 3:F:53:HIS:CD2 2.56 0.403:F:71:VAL:HG22 3:F:90:GLU:HG2 2.03 0.408:H:382:LYS:O 8:H:498:VAL:HA 2.20 0.401:A:1068:SER:O 1:A:1072:ILE:HG12 2.21 0.401:A:440:GLN:HB3 1:A:448:TYR:HD1 1.87 0.401:A:646:PHE:HE2 1:A:707:LEU:HB3 1.86 0.401:A:646:PHE:CZ 1:A:707:LEU:HD23 2.56 0.405:B:121:G:OP1 8:H:518:LYS:HB3 2.14 0.40
2:D:554:ARG:HB3 2:D:584:HIS:CD2 2.56 0.402:D:563:LEU:HG 2:D:565:TYR:HB2 2.04 0.402:D:572:CYS:SG 2:D:579:ILE:HG22 2.59 0.401:A:536:ILE:H 1:A:544:PRO:HA 1.87 0.40
1:A:886:LEU:HA 1:A:886:LEU:HD12 1.89 0.401:A:934:PRO:HB3 1:A:937:ASN:ND2 2.36 0.401:A:996:THR:HA 1:A:999:ASP:OD2 2.22 0.405:B:140:A:H2’ 5:B:141:U:C6 2.57 0.40
2:D:516:SER:HB2 2:D:595:THR:HG21 2.04 0.404:E:65:GLU:CD 4:E:136:MET:O 2.51 0.403:F:10:TYR:CE1 3:F:25:LYS:HB3 2.57 0.405:B:21:G:O2’ 5:B:22:A:O4’ 2.40 0.40
2:D:591:VAL:O 2:D:598:ILE:N 2.42 0.402:D:661:GLU:HG2 2:D:663:ASN:N 2.34 0.40
There are no symmetry-related clashes.
Page 40 Full wwPDB EM Validation Report EMD-7821, 6D6V
5.3 Torsion angles i○
5.3.1 Protein backbone i○
In the following table, the Percentiles column shows the percent Ramachandran outliers of thechain as a percentile score with respect to all PDB entries followed by that with respect to all EMentries.
The Analysed column shows the number of residues for which the backbone conformation wasanalysed, and the total number of residues.
Mol Chain Analysed Favoured Allowed Outliers Percentiles
1 A 970/1117 (87%) 784 (81%) 178 (18%) 8 (1%) 19 59
2 D 183/701 (26%) 162 (88%) 19 (10%) 2 (1%) 14 51
3 F 111/121 (92%) 93 (84%) 18 (16%) 0 100 100
4 E 147/269 (55%) 122 (83%) 24 (16%) 1 (1%) 22 62
8 H 104/542 (19%) 104 (100%) 0 0 100 100
All All 1515/2750 (55%) 1265 (84%) 239 (16%) 11 (1%) 26 62
All (11) Ramachandran outliers are listed below:
Mol Chain Res Type1 A 530 GLN1 A 123 ASN4 E 141 GLN2 D 661 GLU2 D 662 PHE1 A 17 LYS1 A 18 GLU1 A 1006 TYR1 A 85 SER1 A 116 GLY1 A 239 PRO
5.3.2 Protein sidechains i○
In the following table, the Percentiles column shows the percent sidechain outliers of the chainas a percentile score with respect to all PDB entries followed by that with respect to all EMentries.
The Analysed column shows the number of residues for which the sidechain conformation wasanalysed, and the total number of residues.
Page 41 Full wwPDB EM Validation Report EMD-7821, 6D6V
Mol Chain Analysed Rotameric Outliers Percentiles
1 A 931/1069 (87%) 920 (99%) 11 (1%) 71 84
2 D 172/657 (26%) 171 (99%) 1 (1%) 86 92
3 F 107/114 (94%) 105 (98%) 2 (2%) 57 75
4 E 132/242 (54%) 132 (100%) 0 100 100
8 H 95/517 (18%) 94 (99%) 1 (1%) 73 85
All All 1437/2599 (55%) 1422 (99%) 15 (1%) 77 86
All (15) residues with a non-rotameric sidechain are listed below:
Mol Chain Res Type1 A 143 PHE1 A 352 ASN1 A 534 ARG1 A 631 LEU1 A 634 PHE1 A 738 ARG1 A 851 THR1 A 933 ASN1 A 960 PHE1 A 985 ASN1 A 1004 LEU2 D 640 ARG3 F 61 ARG3 F 100 ASP8 H 498 VAL
Sometimes sidechains can be flipped to improve hydrogen bonding and reduce clashes. All (44)such sidechains are listed below:
Mol Chain Res Type1 A 102 ASN1 A 141 ASN1 A 234 HIS1 A 248 ASN1 A 317 ASN1 A 319 HIS1 A 320 ASN1 A 343 GLN1 A 352 ASN1 A 357 GLN1 A 361 ASN
Continued on next page...
Page 42 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type1 A 364 ASN1 A 475 ASN1 A 526 GLN1 A 554 GLN1 A 636 ASN1 A 648 ASN1 A 697 ASN1 A 748 HIS1 A 751 HIS1 A 754 GLN1 A 767 GLN1 A 804 ASN1 A 839 ASN1 A 841 ASN1 A 884 ASN1 A 896 GLN1 A 900 ASN1 A 927 GLN1 A 945 GLN1 A 985 ASN1 A 1016 ASN1 A 1023 ASN1 A 1070 GLN1 A 1098 GLN2 D 576 GLN2 D 606 GLN2 D 612 ASN2 D 629 ASN2 D 656 GLN3 F 52 GLN4 E 40 ASN4 E 127 HIS4 E 143 GLN
5.3.3 RNA i○
Mol Chain Analysed Backbone Outliers Pucker Outliers5 B 158/159 (99%) 103 (65%) 14 (8%)
All (103) RNA backbone outliers are listed below:
Page 43 Full wwPDB EM Validation Report EMD-7821, 6D6V
Mol Chain Res Type5 B 2 U5 B 3 A5 B 4 C5 B 8 C5 B 9 U5 B 11 A5 B 12 A5 B 13 U5 B 14 U5 B 16 A5 B 19 C5 B 20 A5 B 21 G5 B 22 A5 B 24 C5 B 25 U5 B 26 G5 B 27 U5 B 29 A5 B 30 U5 B 31 A5 B 32 G5 B 33 A5 B 34 A5 B 35 C5 B 36 U5 B 37 G5 B 38 U5 B 39 C5 B 40 A5 B 41 U5 B 42 U5 B 43 C5 B 44 A5 B 45 A5 B 46 C5 B 47 C5 B 49 C5 B 50 A5 B 51 A5 B 53 A5 B 54 A5 B 55 U
Continued on next page...
Page 44 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type5 B 56 C5 B 57 U5 B 58 A5 B 59 G5 B 60 U5 B 61 G5 B 62 C5 B 63 U5 B 64 G5 B 66 U5 B 67 A5 B 68 U5 B 69 A5 B 71 C5 B 75 C5 B 76 A5 B 86 U5 B 88 C5 B 89 A5 B 90 A5 B 91 A5 B 92 U5 B 96 U5 B 101 A5 B 106 G5 B 108 A5 B 110 A5 B 111 A5 B 115 A5 B 116 C5 B 117 U5 B 118 A5 B 119 U5 B 122 A5 B 123 C5 B 124 A5 B 125 U5 B 126 U5 B 128 G5 B 129 A5 B 130 U5 B 131 A
Continued on next page...
Page 45 Full wwPDB EM Validation Report EMD-7821, 6D6V
Continued from previous page...Mol Chain Res Type5 B 132 C5 B 133 A5 B 134 C5 B 135 U5 B 136 A5 B 137 U5 B 138 U5 B 140 A5 B 143 A5 B 144 A5 B 145 U5 B 146 G5 B 147 G5 B 154 U5 B 155 A5 B 156 U5 B 157 U5 B 159 U
All (14) RNA pucker outliers are listed below:
Mol Chain Res Type5 B 3 A5 B 33 A5 B 34 A5 B 39 C5 B 41 U5 B 42 U5 B 43 C5 B 46 C5 B 53 A5 B 60 U5 B 65 A5 B 122 A5 B 136 A5 B 137 U
5.4 Non-standard residues in protein, DNA, RNA chains i○
There are no non-standard protein/DNA/RNA residues in this entry.
Page 46 Full wwPDB EM Validation Report EMD-7821, 6D6V
5.5 Carbohydrates i○
There are no monosaccharides in this entry.
5.6 Ligand geometry i○
Of 1 ligands modelled in this entry, 1 is monoatomic - leaving 0 for Mogul analysis.
There are no bond length outliers.
There are no bond angle outliers.
There are no chirality outliers.
There are no torsion outliers.
There are no ring outliers.
No monomer is involved in short contacts.
5.7 Other polymers i○
There are no such residues in this entry.
5.8 Polymer linkage issues i○
There are no chain breaks in this entry.
Page 47 Full wwPDB EM Validation Report EMD-7821, 6D6V
6 Map visualisation i○
This section contains visualisations of the EMDB entry EMD-7821. These allow visual inspectionof the internal detail of the map and identification of artifacts.
No raw map or half-maps were deposited for this entry and therefore no images, graphs, etc.pertaining to the raw map can be shown.
6.1 Orthogonal projections i○
6.1.1 Primary map
X Y Z
The images above show the map projected in three orthogonal directions.
6.2 Central slices i○
6.2.1 Primary map
X Index: 128 Y Index: 128 Z Index: 128
Page 48 Full wwPDB EM Validation Report EMD-7821, 6D6V
The images above show central slices of the map in three orthogonal directions.
6.3 Largest variance slices i○
6.3.1 Primary map
X Index: 123 Y Index: 121 Z Index: 140
The images above show the largest variance slices of the map in three orthogonal directions.
6.4 Orthogonal surface views i○
6.4.1 Primary map
X Y Z
The images above show the 3D surface view of the map at the recommended contour level 0.055.These images, in conjunction with the slice images, may facilitate assessment of whether an ap-propriate contour level has been provided.
Page 49 Full wwPDB EM Validation Report EMD-7821, 6D6V
6.5 Mask visualisation i○
This section shows the 3D surface view of the primary map at 50% transparency overlaid with thespecified mask at 0% transparency
A mask typically either:
• Encompasses the whole structure
• Separates out a domain, a functional unit, a monomer or an area of interest from a largerstructure
6.5.1 emd_7821_msk_1.map i○
X Y Z
Page 50 Full wwPDB EM Validation Report EMD-7821, 6D6V
7 Map analysis i○
This section contains the results of statistical analysis of the map.
7.1 Map-value distribution i○
The map-value distribution is plotted in 128 intervals along the x-axis. The y-axis is logarithmic.A spike in this graph at zero usually indicates that the volume has been masked.
Page 51 Full wwPDB EM Validation Report EMD-7821, 6D6V
7.2 Volume estimate i○
The volume at the recommended contour level is 121 nm3; this corresponds to an approximatemass of 109 kDa.
The volume estimate graph shows how the enclosed volume varies with the contour level. Therecommended contour level is shown as a vertical line and the intersection between the line andthe curve gives the volume of the enclosed surface at the given level.
Page 52 Full wwPDB EM Validation Report EMD-7821, 6D6V
7.3 Rotationally averaged power spectrum i○
*Reported resolution corresponds to spatial frequency of 0.208 Å−1
Page 53 Full wwPDB EM Validation Report EMD-7821, 6D6V
8 Fourier-Shell correlation i○
This section was not generated. No FSC curve or half-maps provided.
Page 54 Full wwPDB EM Validation Report EMD-7821, 6D6V
9 Map-model fit i○
This section contains information regarding the fit between EMDB map EMD-7821 and PDBmodel 6D6V. Per-residue inclusion information can be found in section 3 on page 6.
9.1 Map-model overlay i○
X Y Z
The images above show the 3D surface view of the map at the recommended contour level 0.055at 50% transparency in yellow overlaid with a ribbon representation of the model coloured in blue.These images allow for the visual assessment of the quality of fit between the atomic model andthe map.
Page 55 Full wwPDB EM Validation Report EMD-7821, 6D6V
9.2 Atom inclusion i○
At the recommended contour level, 78% of all backbone atoms, 58% of all non-hydrogen atoms,are inside the map.
Top Related